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Abstract 
 In nature, exposure to chemical insults and toxic agents never occurs in isolation. Any 
number of concurrent exposures can result from environmental factors. The complex network of 
integrated organ systems and metabolic pathways are altered by the presence of different agents, 
so it is possible that, in combination, the biological response to a series of agents might not be 
simply expressed as the sum of individual exposures. A single-compound paradigm, as has been 
the historical norm in both toxicological research and regulatory policy, might be inadequate to 
effectively assess the environmental and health hazards associated with chemical, industrial, or 
engineering processes. A focus on a select few priority compounds may hide the underlying 
toxicities of a given set of samples if we are unable to effectively identify or measure the 
important constituents. Toxicological research into complex mixtures may help to elucidate 
information on the unknowns in a given system and better identify hazards that might not be 
obvious by a narrower, single-compound focus.  In this thesis, the toxicology of two complex 
mixture sources was investigated. The first are complex mixtures of drinking waters 
contaminated with a common pharmaceutical, resulting in the generation of iodinated 
disinfection by-products (DBPs), a set of DBPs that are currently unregulated but have been 
found to be more toxic than their analogs with other halogens. The second investigates a series of 
priority nitrogenous materials derived from a carbon capture process and the complex mixtures 
of by-products. In this comparison, the bulk of toxic effect could not be explained by simply the 
compliment of priority contaminants investigated, but rather the complex mixtures provided 
unexpected insight into more environmentally benign alternatives that would not have been 
realized had the short list of single compounds been the only focus of the research. The research 
demonstrates that, to effectively assess the risks presented by by-products of any of a number of 
processes, complex mixture analysis is essential.  
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CHAPTER 1 
Introduction to Complex Mixtures Toxicology 
 
1.1 Introduction 
 Through the past several decades, toxicologists have recognized that most toxicology 
research struggles with a very profound challenge – exposure is not an isolated event. Chemical 
insults can be acute or chronic in nature and, outside a laboratory setting, never occur as single 
exposures, yet around 95% of toxicological research has focused on single chemical exposures 
[1]. Other stressors present have the potential to alter the potency or effects of individual agents. 
Environmental and organismal factors play important roles in the potential damage of a toxicant. 
Most tangibly, however, exposure to a toxicant might potentially be altered by the presence of 
other toxicants [2]. Interactions can be additive, synergistic, or antagonistic [1]. Humans are 
constantly bombarded with an array of synthetic and natural chemicals – complex mixtures of 
exposure in our daily lives [3]. Toxicology has traditionally focused on the effects of single 
chemical constituents because testing procedures and regulatory oversight are generally focused 
on a handful of important or easy to characterize constituents. This single-compound approach 
can potentially miss yet-to-be characterized components and important biological endpoints 
resulting from chemical interactions [2]. Ultimately, testing of complex mixtures could 
potentially provide more accurate descriptions of our daily experiences with the chemicals 
around us. 
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1.2 Individual Contaminants to Complex Mixture Analysis 
1.2.1 Early Regulations 
 In the United States, Congress has given regulatory authority to a number of executive 
agencies, charging them to establish and enforce standards for contaminants in food, water, and 
occupational exposures. For example, the Safe Drinking Water Act, enacted in 1974, requires the 
United State Environmental Protection Agency (U.S. EPA) to compile a list of priority 
contaminants in drinking water, referred to as the Contaminant Candidate List [4]. This list is 
used to help establish regulatory and research priorities to ensure a safe drinking water supply. 
Contaminants can be either microbial or chemical and include industrial chemicals, pesticides, 
disinfection by-products, and water-borne pathogens. After investigation, the U.S. EPA can 
establish maximum permissible levels of contaminants, referred to as maximum contaminant 
levels (MCL) that, above these concentrations, action can be taken against a violation. 
Identification of priority contaminants begins the regulatory process and is followed by 
regulations on maximum concentrations of individual (or classes of, as is the case for 
trihalomethanes and haloacetic acids) compounds.  This regulatory feature fits the historical 
paradigm of focusing on a single agent or class of agents as a proxy for the net toxicological 
impact of a given drinking water. 
 This “bottom-up” approach, where individual compounds are expected to provide 
sufficient information to characterize the complete mixture, may prove to be inadequate [1]. 
Drinking water disinfection chemically alters constituents of the drinking water to new, 
unexpected chemicals [5]. Half of all halogenated materials in chlorine-treated drinking water 
remain unidentified [6], preventing a single-compound research methodology from even 
beginning to assess the toxicology of potentially important chemical actors [7]. These new 
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chemical species are by-products of the disinfection process – drinking water disinfection by-
products or DBPs – and have their own implications for long-term public health [8]. These 
effects, however, have not received sufficient attention to thoroughly understand their 
significance. Epidemiological studies have correlated certain cancers and adverse reproductive 
outcomes to DBP exposures. Individual DBP agents have been determined to be genotoxins, 
mutagens, teratogens, and carcinogens [8-11]. 
 DBPs are the result of the chemical reactions of naturally-occurring organic matter, 
present in all source waters, and the strong oxidants such as chlorine, chloramine, hydrogen 
peroxide, or ozone. Many DBPs are halogenated. The first major drinking water disinfection by-
products were determined in the 1970s and included the simple halogenated methyl groups. 
These trihalomethanes (THMs) were the first DBPs that were regulated under the Stage 2 rules 
promulgated by the U.S. EPA, under the authority of the Safe Drinking Water Act, and much of 
the existing literature uses this class to estimate the total toxicity and DBP levels of waters [12]. 
 
1.2.2 Unintended Consequences 
 In addressing these early DBPs, the Stage 2 Rules had their own unintended 
consequence. To meet the new compliance standards for total concentrations of DBPs, certain 
utilities have begun to move away from the traditional free chlorine systems of disinfection for 
alternative oxidants such as chloramine. Though the net THM load and the total amount of 
halogenated materials in treated waters is reduced with this alternative oxidant, new classes of 
compounds are more represented and a large percentage of by-products have not been 
characterized at all [13, 14]. The ultimate result of this transition is unknown, but a toolbox of 
toxicological assays can help to understand the implications of an increased burden of other 
4 
 
classes of compounds such as the nitrogenous DBPs and of complex mixtures of the treated 
waters as a whole, more accurately mimicking human exposure to these agents [15]. 
 Drinking water disinfection is changing as new challenges are discovered. Disinfection 
and its byproducts are influenced by the materials present in the source of the water, whether 
natural or anthropogenic. Humic acids, a variety of biological molecules, salts, and metals are all 
present at different levels in even the most pristine of source waters. Especially in surface waters, 
variation in ecosystem activity cause levels of these materials to vary seasonally. New pressures 
on water supplies have resulted in a variety of additional materials to these mixtures, including 
increasing levels of nitrogenous materials from wastewater effluents that are recycled through 
treatment to be used again, rising levels of pharmaceuticals and personal care products, and a 
slew of industrial and agricultural contaminants. These new base materials alter the type and 
levels of DBPs in impacted waters [1, 16, 17]. With additional attention to the regulated DBP 
levels causing utilities to seek out novel technologies to come into compliance with the law, new 
alternatives to chlorine disinfection are producing new reaction conditions that alter the DBPs 
that are generated.  Addressing the health effects of emerging DBPs is becoming ever more 
dynamic and complex. 
 
1.2.3 Emerging Regulatory Authority on Complex Mixtures 
 Continuing this story of contaminants, the regulatory authority governing monitoring and 
control of drinking water has evolved over time through a series of amendments allowing for 
additional protection of source waters, practices to reduce certain contaminants from treatment to 
tap, and additional enforcement powers granted to the U.S. EPA. In 1996, amendments to the 
Safe Drinking Water Act required the Agency to:  
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develop new approaches to the study of complex mixtures, such as mixtures 
found in drinking water, especially to determine the prospects for synergistic or 
antagonistic interactions that may affect the shape of the dose-response 
relationship of the individual chemicals and microbes, and to examine noncancer 
endpoints and infectious diseases, and susceptible individuals and subpopulations. 
Essentially, U.S. EPA must develop methods of analysis to address the potential hazards of 
complex mixtures in a way that departs from the historical single-compound approach to risk 
assessment and public health goals [18]. Research into “top-down” toxicology – that is, an 
assessment of the whole mixture sample, in opposition to the “bottom-up” approach of picking 
constituents and making inference of the total, or top-level toxicology – may help to determine 
other indicators of risk and respond more efficiently to emerging challenges [1, 17, 19]. 
This initiative has not been limited to drinking water. In the same year, Congress passed 
the Food Quality Protection Act of 1996. This act required investigation of complex mixtures of 
residues on foods that are believed to have similar mechanisms of action and therefore possibly 
resulting in enhanced toxicity when agents are combined [20]. The act focuses on pesticide 
residues in foods, but the shift in toxicological and risk assessment moves in the same direction 
as with the amendments to the Safe Drinking Water Act – a recognition that single-chemical 
analysis might be insufficient to protect human health and that analysis of complex mixtures 
might potentially provide more relevant insights to protect human health and the environment. 
Initiatives like these have helped to establish research agendas related to complex 
mixtures. This thesis continues that priority. By selecting important mixtures – the organic 
fraction of disinfected drinking water containing a common contaminant or a large volume 
industrial waste stream – toxicologists can more effectively assess the environmental hazards 
presented by emerging technologies or possible hazards in a comparative manner. This research 
allows for interdisciplinary work with fellow scientists and engineers to determine the important 
factors at play for higher or lower toxicological impacts and allow for better development of less 
6 
 
toxic alternatives and ultimately inform best practices and truly guide protections for public and 
environmental health. The cases presented here assesses generalizable biological endpoints in a 
series of different complex mixtures and some individual chemical agents to identify important 
sources of toxicological impact and allow for a better understanding of the public and 
environmental health risks presented by important water contaminants. 
 
1.3 Complex Mixtures in Toxicology 
1.3.1 Advantages of Analyzing Mixtures 
Regulatory attention has turned towards investigating the potential health hazards of 
complex mixture exposures. There are a number of benefits associated with assessing complex 
mixtures of environmental and industrial origin. 
• Complex mixtures can account for detrimental biological endpoints resulting from 
materials present in environmental samples that are unable to be characterized 
through conventional identification assays due to low concentration levels or high 
molecular weights. 
• Mixtures allow for the assessment of multiple chemical insults at a time, 
providing a complete response to the mixture rather than extrapolating from a few 
select, though not necessarily representative, chemical constituents. 
• Mixtures present a more relevant picture of exposure than individual compound 
assays. Ultimately, regulations are intended to protect biological systems and 
organisms; therefore, testing more relevant exposures like complex mixtures 
provide more relevant insight to biological endpoints of concern. 
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These are the driving reasons behind complex mixture assessment as an additional research focus 
to single-compound toxicological assays [1, 19, 21, 22]. 
 Any combination of chemical agents, known or unknown, qualitatively or quantitatively, 
can be a mixture. Early toxicological work on mixtures involved two or more agents in defined 
concentrations. These well-defined mixtures with a limited number of species are considered to 
be “simple” mixtures. This type of testing can be useful if a specific pathway or mechanism is 
expected to be at work for a given biological endpoint. The better characterized a mixture is, the 
more easily its action can be teased out of experimental data. These experiments are also 
typically not limited by sample size, as a new stock can be made by mixing chemical standards. 
Because simple mixtures are more easily controlled, they are generally easier to work with [1]. 
Mixtures with ten or more chemical constituents are generally considered “complex.” 
Frequently, concentrations of individual chemical species in complex mixtures are unknown. If 
the mixture contains undefined constituents, it is also considered to be a complex mixture. 
Environmental samples that contain too many different constituents to characterize can be 
studied as complex mixtures and can provide important insight into the “real world” effects of 
contamination. Complex mixtures can more accurately represent the multitude of exposures 
organisms face at any time [1].  
 
1.3.2 Difficulties of Testing Complex Mixtures 
Unfortunately, there are some difficulties associated with analyzing complex mixtures.  
• Complex mixtures tend to be less stable than well-defined, simple ones.  
• Extraction efficiency can present problems when environmental samples are 
being prepared for analysis.  
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• Environmental samples are snapshots of dynamic systems and processes. 
Chemical constituents are ever-changing in a dynamic environmental system. 
Seasonal changes, meteorological patterns, and unknown factors can all influence 
the uncharacterized portion of an environmental sample used for testing. A 
representative sample from one time point may change dramatically between 
samplings. Samples taken from even the most controlled of industrial settings 
may have variables that are impossible to control for, generating greater 
variability than single-compound or simple mixture samples [23]. 
• Sample size can present a challenge. Environmental or industrial samples must be 
taken all at one time, which can be limited by the size of a reactor or the vessel for 
sampling. For testing and repeats, this must be a substantial volume. Ideally, 10-
20 L of water is necessary for a single mixture to complete a battery of assays in 
efficient in vitro systems. If volumes of this scale are unavailable, the statistical 
power of the work can be limited. Whole animal studies of complex mixtures 
require incredible volumes of material that hinder their capacity to achieve 
statistical significance (for an important design, see [16]). 
• Toxicological assays are conducted to determine generalizable conclusions, yet 
the more complex the mixture, the more specific the results become. Determining 
“how similar is similar” is an additional challenge to complex mixtures that is less 
of an issue in simple mixture or single compound analyses. 
Despite these research challenges, the benefits of complex mixtures’ insight into public health 
risks and outcomes outweigh the drawbacks and limitations of this type of research [22]. 
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1.4 Research Projects 
This thesis focuses on two projects of interest. The first addresses the issue of emerging 
contaminants, either recently detected of the result of new chemical contaminants or processes, 
in drinking water supplies and the unexpected outcomes of drinking water disinfection. 
Iopamidol, a widely-used X-ray contrast medium and common pharmaceutical contaminant of 
surface and ground waters, is investigated as a potential source of highly toxic iodinated 
disinfection by-products. The specific chemistry of iopamidol’s degradation is still unknown. 
The biological feedback of toxicological assays of these complex mixtures allows for profiles of 
toxicity to be compared even without the identities of all of the individual degradation products. 
Different methods of disinfection are explored to more broadly determine the patterns of by-
product generation. Here, differences in complex mixtures allow us to glean important chemical 
characteristics for further exploration in a way that would be impossible in a traditional single-
chemical assay. 
In the second project, the industrial waste generated by an amine-based carbon capture 
project is examined for its cytotoxicity and genotoxicity from both the complex mixture and 
single agent methods. Effluent from the combustion reaction is treated with amine mixtures at 
variable conditions to optimize for carbon capture efficiency, resulting in different end mixtures 
of chemicals. Special attention was given to high volume nitrogenous materials that were 
expected to be major contributors to the effluents’ overall cytotoxicity and genotoxicity. The 
results of the single-compound nitrosamines and nitramines provide references applicable to 
other mixtures containing nitrogenous materials, while the results of the complex mixture 
assessments help to determine whether or not these priority contaminants are actually driving the 
toxicological responses seen in the total effluent. The complex mixtures also provided a means 
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of comparison between different solvents and reactor conditions, allowing for the company to 
determine which of the processes and proprietary solvents would be the least toxic of its options. 
 
1.5 Research Objectives 
• Assess, in a comparative manner, the organic fractions from these sample complex 
mixtures 
• Compare generalizable biological endpoints (cytotoxicity, genotoxicity, 
mutagenicity) across chemical treatment groups to identify key components that 
might serve as measurable indicators of enhanced toxicity 
• For the nitrogenous materials in the second project, assess the toxicity of important 
individual constituents to determine whether or not these chemical agents are the 
primary contributors to the overall toxic response 
• Assess chemical conditions of samples (choice of disinfectant, presense or absence of 
important contaminants, reaction conditions) to identify process-based toxicological 
outcomes 
• Provide clear, meaningful feedback to utilities or industry so as to inform engineering 
processes with biological information, relying on measures that have been used 
previously such as “toxic equivalence factors” [24] 
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CHAPTER 2 
Formation of Toxic and Iodinated Disinfection By-Products from  
Compounds used in Medical Imaging1,2 
 
2.1 Abstract 
 Iodinated X-ray contrast media (ICM) were investigated as a source of iodine in the 
formation of iodo-trihalomethane (iodo-THM) and iodo-acid disinfection by-products (DBPs), 
both of which are highly genotoxic and/or cytotoxic in mammalian cells.  ICM are widely used 
at medical centers to enable imaging of soft tissues (e.g., organs, veins, blood vessels) and are 
designed to be inert substances, with 95% is eliminated in urine and feces unmetabolized within 
24 h.  ICM are not well removed in wastewater treatment plants, such that they have been found 
at elevated concentrations in rivers and streams (up to 100 µg/L).  Naturally occurring iodide in 
source waters is believed to be a primary source of iodine in the formation of iodo-DBPs, but a 
previous 23-city iodo-DBP occurrence study also revealed appreciable levels of iodo-DBPs in 
some drinking waters that had very low or no detectable iodide in their source waters.  When 10 
of the original 23 cities’ source waters were re-sampled, four ICM were found—iopamidol, 
iopromide, iohexol, and diatrizoate—with iopamidol most frequently detected, in 6 of the 10 
plants sampled, with concentrations up to 2700 ng/L.  Subsequent controlled laboratory reactions 
of iopamidol with aqueous chlorine and monochloramine in the absence of natural organic 
matter (NOM) produced only trace levels of iodo-DBPs; however, when reacted in real source 
                                                           
1
 Reprinted, with permission, from Duirk, S. E., Lindell, C., Cornelison, C. C., Kormos, J., Ternes, T. A., Attene-
Ramos, M., Osiol, J., Wagner, E. D., Plewa, M. J., Richardson, S. D. (2011) “Formation of Toxic Iodinated 
Disinfection By-Products from Compounds  Used in Medical Imaging.” Environmental Science and Technology 
45(16): 6845-6854 
2
 For this paper, I was responsible for the cytotoxicity and genotoxicity assays conducted on sample sets with 
chloramination as the method of disinfection. 
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waters (containing NOM), chlorine and monochloramine produced significant levels of iodo-
THMs and iodo-acids, up to 212 nM for dichloroiodomethane and 3.0 nM for iodoacetic acid, 
respectively, for chlorination.  The pH behavior was different for chlorine and monochloramine, 
such that iodo-DBP concentrations maximized at higher pH (8.5) for chlorine, but at lower pH 
(6.5) for monochloramine.  Extracts from chloraminated source waters with and without 
iopamidol, as well as from chlorinated source waters with iopamidol, were the most cytotoxic 
samples in mammalian cells.  Source waters with iopamidol but no disinfectant added were the 
least cytotoxic.  While extracts from chlorinated and chloraminated source waters were 
genotoxic, the addition of iopamidol enhanced their genotoxicity.  Therefore, while ICM are not 
toxic in themselves, their presence in source waters may be a source of concern because of the 
formation of highly toxic iodo-DBPs in chlorinated and chloraminated drinking water.   
 
2.2 Introduction 
In a previous 23-city occurrence study, we measured the widespread presence of iodinated 
disinfection by-products (iodo-DBPs)—iodo-acids and iodo-trihalomethanes (iodo-THMs)—in 
chloraminated and chlorinated drinking water in the United States and Canada, up to 10.2 µg/L 
and 1.7 µg/L for individual iodo-THMs and iodo-acids, respectively [1].  Iodo-DBPs are highly 
genotoxic and cytotoxic, with iodoacetic acid being the most genotoxic DBP identified to-date 
[1, 2].  The primary source of iodine in iodo-DBPs is believed to be from natural iodide in source 
waters, and most plants in this previous study showed increasing levels of iodo-DBPs with 
increasing levels of natural iodide, which is to be expected, based on known 
iodide/chloramination chemistry [3, 4].  However, natural iodide levels were very low or not 
detected in some cases (e.g., Plants 2, 4, 11, and 15), such that iodo-DBP formation could not be 
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completely accounted for by natural iodide concentrations in the source waters (Table A.1, 
Supporting Information [SI]).  Therefore, we investigated other potential sources of iodine that 
could contribute to iodo-DBP formation. 
Iodinated X-ray contrast media (ICM) are widely used to enable medical imaging of soft 
tissues (e.g., organs, veins, blood vessels).  ICM are large molecules (~600-700 Da) with 
triiodobenzoic acid analogues in their basic structures (Figure 2.1).  Global consumption of ICM 
is approximately 3.5 × 106 kg/year; a single application can be up to 200 g.  ICM are designed to 
be inert, with 95% unmetabolized and eliminated in urine and feces within 24 h [5].  Individual 
ICM differ mainly in their side chains, which contain hydroxyl, carboxyl, and amide moieties to 
impart elevated polarity and aqueous solubility [6].  
Due to their incomplete removal in wastewater treatment plants, ICM have been found at 
elevated concentrations in rivers and streams [7-11].  Concentrations as high as 100 µg/L have 
been detected in a creek containing more than 50% wastewater [12].  ICM have also been found 
in groundwater and drinking water because they are somewhat recalcitrant during soil-aquifer 
passage and are not completely removed by activated carbon filtration or ozonation [10, 13-18].  
ICM are primary contributors to the total organic halogen burden in clinical wastewater [19].  
More than 90 % of the adsorbable organic iodine in wastewater and surface water can be 
attributed to ICM [9, 11, 14, 19-21].  Recently, Schulz et al. [22] and Kormos et al. [23, 24] 
identified 46 biotransformation products (TPs) of the nonionic ICM, iopromide, iohexol, 
iomeprol, and iopamidol from aerobic soil−water and sediment−water systems.  These TPs, 
which still contain iodine in their structures, were subsequently found in municipal wastewater 
effluents [22-25].  
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DBPs are generally formed by the reaction of disinfectants with natural organic matter 
(NOM), but anthropogenic contaminants can also react with disinfectants to form DBPs.  
Contaminant DBPs have been reported for pharmaceuticals, personal care products, estrogens, 
pesticides, textile dyes, alkylphenol surfactants, UV filters, and diesel fuel [26].  Contaminants 
with activated benzene rings or other functional groups that can react with chlorine and other 
oxidants are potential DBP precursors.  Because of the widespread presence of ICM and the 
relatively high levels observed in surface waters, we investigated them as a potential source of 
the iodine in iodo-THM and iodo-acid DBPs in chlorinated and chloraminated drinking water.  
 
2.3 Materials and Methods 
2.3.1 Chemicals and Reagents   
Iopamidol, iomeprol, iopromide, iohexol, and sodium diatrizoate were purchased from 
U.S. Pharmacopeia (Rockville, MD), Polysciences (Warrington, PA), Schering (Berlin, 
Germany), or Byk Gulden (Konstanz, Germany) at purities of 100, 97, 97.9, 100, and 100%, 
respectively.  Iodo-THMs (dichloroiodomethane, bromochloroiodomethane, 
dibromoiodomethane, chlorodiiodomethane, bromodiiodomethane, and iodoform) and iodoacids 
(iodoacetic acid, bromoiodoacetic acid, (Z)-3-bromo-3-iodo-propenoic acid, (E)-3-bromo-3-
iodo-propenoic acid, and (E)-2-iodo-3-methylbutenedioic acid) were purchased at the highest 
level of purity from Orchid Cellmark (New Westminster, BC, Canada), CanSyn Chem. Corp. 
(Toronto, ON, Canada), and Sigma-Aldrich.  Commercial 10-13% sodium hypochlorite 
(NaOCl), purchased from Aldrich (Milwaukee, WI), contained equal-molar amounts of OCl- and 
Cl-.  All other organic and inorganic chemicals were certified ACS reagent grade and used 
without further purification.   
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2.3.2 Controlled Laboratory Reactions   
Aqueous stock solutions and experiments utilized purified water (18 MΩ cm-1) from a 
Barnstead ROPure Infinity/NANOPure  system (Barnstead-Thermolyne Corp., Dubuque, 
IA).  The pH was monitored with an Orion 940 pH meter equipped with a Ross combination 
electrode (Thermo Scientific, Waltham, MA).  For pH adjustment, either 1 N H2SO4 or NaOH 
was used prior to oxidant addition.  Glassware and polytetrafluoroethylene (PTFE) septa were 
soaked in a concentrated free chlorine solution (6%) for 24 h, rinsed with deionized water, and 
dried prior to use.  Source waters (Oconee River) were obtained from the Athens-Clarke County 
(ACC) Drinking Water Treatment Plant in Athens, GA, and filtered (using 5.0 and 0.45 µm 
filters, Millipore Corp., Billerica, MA) prior to use.  Source water characteristics are shown in 
Table A.2.  Chlorination kinetic experiments were conducted under pseudo first-order conditions 
with total chlorine, [Cl2]T, to iopamidol molar ratios of 5:1, 6.7:1, 10:1, 20:1, and 40:1.  Chlorine 
was added to solutions under rapid-mix conditions using a magnetic stir plate and a PTFE-coated 
stir bar.  Reactions were conducted over 72 h and in duplicate unless otherwise stated.  The pH 
was maintained using 10 mM of phosphate (pH 6.5 and 7.5), borate (pH 8.5), or carbonate (pH 
9.0) salts.  Aqueous chlorine solutions were diluted to 250 mM and added to the aqueous 
solution containing iopamidol and buffer in a 500 mL Erlenmeyer flask.  Four aliquots were then 
placed into 120 mL amber reaction vessels with PTFE septa and stored in the dark at 25 °C.  
Monochloramine experiments followed the same experimental protocol, and utilized additions of 
preformed monochloramine to avoid potential artifacts caused by reactions of excess free 
chlorine that may briefly exist if monochloramine was formed in-situ (27).  Monochloramine 
solutions were prepared by mixing 5.64 mM ammonium chloride with 3.7 mM hypochlorous 
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acid to achieve the desired 0.7 Cl/N molar ratio.  The solution was allowed to react and 
equilibrate for 30 min in 10 mM bicarbonate buffer, pH 8.5, prior to use. 
Oxidant residuals were quenched with 120 µM sodium sulfite (20% excess of initial 
chlorinated oxidant concentration; prepared fresh in deoxygenated water).  The stability of iodo-
DBPs in the presence of sodium sulfite was examined and is discussed in Supporting 
Information.  Samples were extracted immediately after quenching to eliminate the chance for 
potential degradation of iodo-DBPs.  At the end of each experiment, residual aqueous oxidant 
concentrations were determined using the N, N-diethyl-p-phenylendiamine titrimetric method 
[28].  
 
2.3.3 ICM Measurements   
Source waters were collected from drinking water treatment plants from 10 of the 23 
cities in the 23-city iodo-DBP occurrence study [1].  Samples were collected in 2-L Teflon 
bottles (headspace free) and shipped on ice packs (2-day delivery) to the Federal Institute of 
Hydrology (Koblenz, Germany).  Water samples were extracted using solid-phase extraction and 
analyzed using liquid chromatography (LC)/electrospray ionization (ESI)-mass spectrometry 
(MS)/MS, according to a previously published method [12].  Further details are also available in 
SI.   
 
2.3.4 Iodo-THM, Iodo-acid, Iodate, and Iodide Measurements   
Iodo-THM measurements were carried out using liquid-liquid extraction and gas 
chromatography (GC) with electron ionization-MS; iodo-acid measurements were carried out 
using liquid-liquid extraction, diazomethane derivatization, and detection by GC/negative 
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chemical ionization (NCI)-MS, according to a previously published method with minor 
modification [1].  Iodide and iodate were measured using ion chromatography (Dionex LC30 
chromatography oven, ASRS ion suppressor, AD25 absorbance detector).  Further details are 
available in SI.   
 
2.3.5 Total Organic Carbon and SUVA Measurements   
Total organic carbon (TOC) was measured using a Shimadzu TOC 5000 (Shimadzu 
Scientific, Columbia, MD).  UV absorbance was measured using a Shimadzu UV1601 
spectrophotometer. 
 
2.3.6 Mammalian Cell Cytotoxicity and Genotoxicity   
Mammalian cell cytotoxicity and genotoxicity measurements were conducted on organic 
extracts of source waters (20 L each) spiked with iopamidol (5 µM) and treated with chlorine or 
monochloramine.  Controls included raw source waters spiked with iopamidol (no oxidant) and 
raw source waters treated with chlorine or monochloramine (no iopamidol).  Treated waters were 
concentrated using XAD resins (40 mL XAD-8 over 40 mL XAD-2), as described in a 
previously published procedure [29].  Chinese hamster ovary (CHO) cells, line AS52, clone 11-
4-8 were used for the cytotoxicity and genotoxicity analyses of the water concentrates [30].  
These assays have been described in the literature [31, 32]; detailed descriptions of each assay 
are presented in SI.  For chronic cytotoxicity (72-h exposure), a series of concentrations were 
analyzed with 4-8 replicates per concentration.  A concentration-response curve was generated 
and regression analysis used to calculate the %C½ value.  This value is analogous to LC50 and is 
the concentration that induced a cell density at 50
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of variance (ANOVA) test was conducted to determine whether the water concentrate induced a 
significant level of cell killing. If a significant F value (P ≤ 0.05) was obtained, a Holm-Sidak 
multiple comparison versus the control group analysis was conducted.  The power of the test 
statistic was maintained as 0.8 at α = 0.05.  To determine the acute genotoxicity of the water 
concentrates, single-cell gel electrophoresis (SCGE) was employed; it quantitatively measures 
genomic DNA damage induced in individual nuclei of treated cells [32].  CHO cells were 
exposed for 4 h at 37°C, 5% CO2.  Each experiment included a negative control, a positive 
control (3.8 mM ethylmethanesulfonate), and 9 water extract concentrations.  The concentration 
range was determined by measuring acute cytotoxicity with a vital dye.  After treatment, cells 
were harvested, embedded in an agarose microgel, and lysed; the DNA was denatured and 
electrophoresed under alkaline conditions.  Using Komet 3.1 software, the primary measure of 
DNA damage was the % tail DNA which is the amount of DNA that migrated from the nucleus 
into the agarose gel.  Within the concentration range that allowed for 70% or greater viable cells, 
a concentration-response curve was generated, and a regression analysis was used to fit the 
curve.  The SCGE genotoxic potency value was determined as the midpoint of this curve.  The % 
tail DNA value for each microgel was determined, and the data were averaged among all 
microgels for each water extract concentration.  The % tail DNA values were analyzed with an 
ANOVA test.  If a significant F value (P ≤ 0.05) was obtained, a Holm-Sidak multiple 
comparison versus the control group analysis was conducted.  The power of the test statistic was 
maintained as 0.8 at α = 0.05. 
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2.4 Results and Discussion 
2.4.1 Discovery of ICM in Source Waters  
When source waters for 10 of the original 23 cities in the iodo-DBP occurrence study were 
reexamined for the presence of five commonly used ICM, four of them were detected:  
iopamidol, iopromide, iohexol, and diatrizoate (Table 2.1).  Iopamidol was the ICM most 
frequently detected, in 6 of the 10 plants sampled, up to 2700 ng/L.   
 
2.4.2 Controlled Laboratory Reactions   
As a result, controlled laboratory reactions were initiated to determine whether iopamidol 
could be a source of iodine in the formation of iodo-THM and iodo-acid DBPs in drinking water.  
When iopamidol was reacted with free chlorine in purified water (in the absence of NOM), only 
trace levels of iodo-DBPs were observed (e.g., dichloroiodomethane ranged from 2.2 to 10.7 nM 
and iodo-acids were not detected; Table A.3).  However, when iopamidol was dissolved in actual 
source waters (river water), chlorination produced significant levels of iodo-DBPs, up to 212 nM 
for dichloroiodomethane and 3.0 nM iodoacetic acid (Figure 2.2; Table A.3).  
Dichloroiodomethane and chlorodiiodomethane were the predominant iodo-THMs formed, and 
iodoacetic acid was the predominant iodo-acid formed.  Other iodo-acids were occasionally 
detected, but were always below the minimum quantification limit (0.5 nM).  Iodate was also 
formed with maximum formation at pH 7.5 and 8.0 (Figure A.1).  In contrast, no iodo-DBPs 
were detected in a control of the same raw source water reacted with chlorine in the absence of 
iopamidol.  It is evident that both NOM and iopamidol are important precursors in the formation 
of iodo-DBPs and that iopamidol was likely the source of iodine in the structures of these iodo-
DBPs.  In general, iodo-THMs were increased in formation with chlorine at higher pH (pH 7.5 
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and 8.5, relative to pH 6.5), with up to 212 nM of dichloroiodomethane at pH 8.5 vs. 43.7 nM at 
pH 6.5.   
Monochloramine also produced iodo-DBPs from iopamidol in NOM-containing source 
waters, but the pH trend was the opposite of chlorine, such that increased iodo-DBPs were found 
at lower pH (6.5) (Figure 2.2, Table A.3).  Overall, iodo-THM concentrations were much lower 
with monochloramine as compared to chlorine.   
Because this is the first report of DBPs from an ICM, we investigated the potential for 
iodide or other impurities in the iopamidol that could be responsible for iodo-DBP formation.  
While the iopamidol was reported by the manufacturer to be 100% pure, a 2 g/L solution was 
prepared in purified water and analyzed for the presence of iodide impurities with ion 
chromatography.  With detection limits for iodide (and iodate) of 1.0 µM, no inorganic iodide 
compounds were observed.  In addition, we dissolved iopamidol in methanol and analyzed by 
full-scan GC/MS for potential impurities, as well as extracted iopamidol in purified water with 
ethyl acetate and analyzed this extract by full-scan GC/MS.  Half of this extract was also 
derivatized with diazomethane to investigate for carboxylic acid impurities.  When these samples 
were compared to their corresponding solvent/derivatization blanks, no impurities were detected.  
A similar check by LC/MS/MS revealed no signs of impurities in the iopamidol.  In addition, the 
formation of iodo-DBPs and/or disappearance of iopamidol were consistently observed with 
different lots of iopamidol and with two different source waters (Oconee River, Athens, GA, and 
Rhine River, Koblenz, Germany) collected over separate times of the year.  In separate 
experiments conducted with Suwannee River fulvic and humic acid as the NOM source in 
purified water (SI), iodo-THMs and iodo-acids were formed at increasing levels with increasing 
fulvic/humic acid doses and behavior was comparable to that observed with real source waters 
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(Figure A.2).  Therefore, all data pointed to the iodo-DBPs being formed by the iopamidol itself 
(along with NOM) and did not appear to be an artifact from potential impurities.   
Iodo-DBP formation was also investigated as a function of increasing iopamidol dose and 
time.  Figure 2.3 shows the formation of dichloroiodomethane as a function of increasing 
iopamidol dose and time at pH 8.5.  From these data, it is evident that iodo-DBPs increased in 
formation with increasing levels of iopamidol.  To understand the reaction of iopamidol with 
aqueous chlorine, iopamidol degradation experiments were conducted in the presence of excess 
aqueous chlorine over the pH range of 6.5-9 without NOM present.  A plot of the pseudo first-
order rate constant vs. pH shows an increase in reaction rate of chlorine with iopamidol from pH 
6.5 to 9.0, with the rate leveling off at pH 8.0-9.0 (Figure A.3).  The pH dependence suggests 
that OCl- may be the primary reactive species with iopamidol (pKa of 7.5 for dissociation of 
HOCl to OCl-) (Figure 2.4).  In reactions involving monochloramine, we also propose that OCl- 
may be the primary reactive species.  Below pH 8.5, where increased iodo-DBP levels were 
observed, monochloramine is less stable and hydrolyzes to form HOCl and NH3.  When excess 
concentrations of ammonia were applied (chlorine:ammonia molar ratios of 0.7, 0.5, 0.1, 0.05, 
and 0.025 mol/mol) at pH 8.5, concentrations of iodo-DBPs and iodate were monitored as a 
function  of time.  Iodate was not formed, and the concentrations of iodo-DBPs were reduced by 
60% or greater as function of increasing residual ammonia concentrations.  Excess ammonia 
favors the formation of NH2Cl and inhibits the hydrolysis back-reaction to form HOCl (and  
OCl-) (Figure 2.4).  Hypochlorite ion may be the reacting species, but not by the conventional 
known iodide oxidation pathway [3, 4].  OCl- is known to act as a nucleophile towards 
tetrahedral phosphorus and carbonyl functional groups [33, 34].  From preliminary investigations 
of high molecular weight reaction species, it appears that OCl- may be initially attacking one of 
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the amide side chains; however, the detailed mechanism is not known at this time.  Complete 
product studies of iopamidol in the presence of aqueous chlorine are currently in progress. 
 
2.4.3 Comparison Reactions with Iodide   
In separate experiments, raw source waters were spiked with 5 µM iodide and reacted 
with chlorine or monochloramine to compare with the iopamidol reactions.  As expected from 
the iodo-DBP occurrence study [1] and from a previous controlled laboratory study that 
measured iodo-THMs [3], chloramine plus iodide formed much higher levels of iodo-DBPs than 
chlorine plus iodide (Figure 2.5).  Dichloroiodomethane and iodoacetic acid were formed at a 
maximum of 579 and 39 nM, respectively, in the chloraminated water, and up to 114 and 3.7 
nM, respectively, in the chlorinated water.  The behavior was quite different from reactions with 
iopamidol, where chlorine forms higher levels than monochloramine.  It should be noted that in 
these experiments with iodide, chlorine was completely consumed at 24 h, while 
monochloramine had measurable residuals at 72 h.  This is different from reactions with 
iopamidol, where chlorine residuals were still detectable at 72 h.  The rapid reaction of chlorine 
with iodide is consistent with the rapid sequential oxidation of iodide to iodate (Figure A.4), 
which happens with chlorine, but not with monochloramine, due to much slower rates of 
oxidation of hypoiodous acid (HOI) to iodate [33, 34].  Iodo-THM and iodo-acid levels 
measured in the chlorine reactions at 24, 48, and 72 h were essentially the same, such that there 
was no degradation (e.g., hydrolysis) over 72 h at pH 6.5, 7.5, and 8.5. 
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2.4.4 Mammalian Cell Cytotoxicity and Genotoxicity   
Because iodo-THMs and iodo-acids are known to be cytotoxic and/or genotoxic, we 
investigated the mammalian cell cytotoxicity and genotoxicity of the reaction mixtures of 
chlorine or monochloramine with iopamidol and NOM.  Mammalian cell cytotoxicity and 
genotoxicity results supported the formation of toxic iodo-DBPs from iopamidol.  Concentration-
response curves for experiments that measured chronic CHO cell cytotoxicity with chlorine or 
chloramine as the disinfectant are presented in Figure 2.6A and 2.6B, respectively.  Comparative 
chronic CHO cell cytotoxicity demonstrated that extracted ACC water was one of the least toxic 
samples (%C½ = 158.1×, Table 2.2), as well as an extraction of a pure water blank (data not 
shown).  ACC water with iopamidol from two different sampling experiments expressed an 
average %C½ value of 127.4×, which suggests that these organic extracts are slightly more 
cytotoxic than the ACC source water extracts (Table 2.2).  Disinfection with chlorine or 
chloramine increased the cytotoxicity of the extracts by 4.5-fold or 7.1-fold, respectively, based 
on their %C½ values (Figure 2.6A, 2.6B, Table 2.2).  Finally, extracts from reaction mixtures 
containing iopamidol and chlorine in ACC water was slightly more cytotoxic than the 
corresponding source waters treated with chlorine (Figure 2.6A).  For chloramine disinfection, 
there appears to be little effect on chronic cytotoxicity with or without iopamidol (Figure 2.6B, 
Table 2.2).   
Experiments that measured genomic DNA damage with chlorine or chloramine as the 
disinfectant are presented in Figures 2.6C and 2.6D, respectively.  Organic extracts from ACC 
water alone or ACC water with iopamidol were negative or very weakly genotoxic.  After 
disinfection by chlorine or chloramine, the ACC source water extracts expressed significant 
genotoxicity because of DBP formation.  Notably, the addition of iopamidol in ACC water 
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disinfected with chlorine or chloramine resulted in a 1.7-fold or 1.3-fold increase in genotoxicity, 
respectively (Figure 2.6C, 2.6D, Table 2.2).   
In Table A.4 (SI), we calculated the weighted impact by the analyzed iodo-DBPs that 
resulted in the toxicity observed in Figure 2.6.  These data indicate that the descending rank 
order of the iodo-DBPs that contributed to the greatest cytotoxicity response for the chlorinated 
water sample (with iodopamidol) was iodoacetic acid (IAA) > ClI2 > Cl2I > I3 > ClBrI.  The 
descending rank order for the chloraminated water sample (with iopamidol) was IAA > ClI2 > 
Cl2I.  Clearly, the major driver of chronic cytotoxicity was the presence of IAA.  IAA was also 
implicated as the iodo-DBP agent inducting the largest level of genotoxic response in these water 
samples. 
During the past decade, we demonstrated that iodinated DBPs are generally more 
cytotoxic and genotoxic than their brominated or chlorinated analogs.  This trend holds true for 
DBP classes including the THMs [1, 31], haloacids [1, 2, 35], haloacetonitriles [36], and 
haloacetamides [37].  Recent comparative human cell toxicogenomic analyses of the 
monohaloacetic acids demonstrated that iodoacetic acid modified the expression of more human 
genes associated with adverse health outcomes than bromo- or chloroacetic acid [38].  The fact 
that iopamidol can generate iodo-DBPs after disinfection and that iodo-DBPs demonstrate higher 
levels of toxicity support concerns that ICM may have adverse impacts upon public health and 
the environment when they are released into wastewaters. 
 
2.5 Future Research and Implications   
As indicated in the previous 23-city iodo-DBP occurrence study, natural iodide is 
probably still the most important source of iodine in the formation of iodo-DBPs, especially for 
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chloraminated drinking waters [1].  However, it is evident from the current study that the ICM, 
iopamidol, can also be a source of iodine in these DBPs for both chlorinated and chloraminated 
drinking water.   
 Of the ICM investigated to-date, iopamidol appears to be the most important contributor 
to iodo-DBP formation.  Preliminary experiments were conducted using two other ICM (iohexol 
and iopromide) that were found in three of the 10 source waters re-sampled from the 23-city 
iodo-DBP occurrence study.  Similar to iopamidol, iohexol and iopromide formed only trace 
levels of iodo-DBPs when chlorination and chloramination reactions were carried out in purified 
water (in the absence of NOM).  But, unlike iopamidol, which produced significant levels of 
iodo-DBPs in real source waters (containing NOM) treated with chlorine and monochloramine, 
iohexol and iopromide did not form appreciable levels (Tables A.5 and A.6, SI).  Further 
research is underway to understand this behavior and also to establish a detailed mechanism of 
formation of iodo-DBPs from iopamidol, including the site of initial reaction with 
chlorine/monochloramine, high molecular weight iopamidol intermediates, and toxicity resulting 
from these reactions.   
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2.7 Supporting Information 
Additional information on experimental methods, including additional figures and tables 
follows in Appendix A.  
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  Table 2.1 ICM in U.S. Drinking Water Sources (ng/L) 
 Iopamidol Iomeprol Iopromide Iohexol Diatrizoate 
Plant 1 11 <10 <10 <10 <10 
Plant 2 510 <10 24 120 93 
Plant 4 110 <10 6 49 <10 
Plant 10 <10 <10 <10 <10 <10 
Plant 11 100 <10 <10 85 <10 
Plant 12 280 <10 <10 120 <10 
Plant 13 <10 <10 <10 <10 <10 
Plant 15 2700 <10 25 <10 <10 
Plant 17 <10 <10 <10 <10 <10 
Plant 19 <10 <10 <10 <10 <10 
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Table 2.2 CHO Cell Chronic Cytotoxicity and Acute Genotoxicity of Water Concentrates 
 
CHO Cell Chronic Cytotoxicity Results 
Water Samples a Conc. 
Factor 
Range 
(×-Fold) 
%C½ 
Value 
(LC50) b 
R2 c Lowest 
Toxic 
Conc. 
Factor d 
ANOVA Statistic e 
ACC Water + Iopamidol f 10 - 200 85.9× 0.98 50.0× F10, 117 = 58.1; P ≤ 0.001 
ACC Water + HOCl 5 - 50 35.0× 0.96 30.0× F12, 168 = 34.3; P ≤ 0.001 
ACC Water + Iopamidol + HOCl 5 - 50 23.5× 0.99 10.0× F10, 105 = 159; P ≤ 0.001 
ACC Water + Iopamidol f 10 - 350 168.9× 0.99 100× F10, 77 = 314; P ≤ 0.001 
ACC Water + NH2Cl 5 - 50 22.4× 0.99 20× F10, 77 = 378; P ≤ 0.001 
ACC Water + Iopamidol + NH2Cl 5 - 50 23.5× 0.98 20× F10, 77 = 563; P ≤ 0.001 
ACC Water  10 - 350 158.1× 0.99 75× F10, 77 = 185; P ≤ 0.001 
 
CHO Cell Acute Genomic DNA Damage (SCGE) Results 
Water Samples Conc. 
Factor 
Range 
(×-Fold) 
SCGE 
Genotox
Potency 
Value g 
R2 h Lowest 
Genotox 
Conc. 
Factor i 
ANOVA Statistic 
ACC Water + Iopamidol f 40-1000 NG j NA NS k F13, 20 = 1.39; P = 0.25 
ACC Water + HOCl 40 - 480 285× 0.75 240× F12, 41 = 17.2; P ≤ 0.001 
ACC Water + Iopamidol + HOCl 40 -240  166× 0.95 160× F10, 39 = 21.2; P ≤ 0.001 
ACC Water + Iopamidol f 120-1000 NG NA 800× F9, 49 = 3.52; P ≤ 0.002 
ACC Water + NH2Cl 120-1000 760× 0.88 800× F21, 98 = 6.92; P ≤ 0.001 
ACC Water + Iopamidol + NH2Cl 120-1000 588× 0.93 520× F21, 38 = 25.3; P ≤ 0.001 
ACC Water  120 - 1000 NG NA NS F9, 50 = 1.69; P = 0.12 
 
a Athens-Clarke County (ACC) source water (river water) with and without disinfection and with 
and without iopamidol (IPM).  b The %C½value is the concentration factor of the extract 
determined from a regression analysis of the data that induced a cell density of 50% as compared 
to the concurrent negative control.  c The coefficient of determination for the regression analysis 
upon which the %C½ value was calculated.  d Lowest toxic concentration factor of the water 
concentrate in the concentration-response curve that induced a significant reduction in cell 
density as compared to the negative control.  e The degrees of freedom for the between groups 
and residual associated with the calculated F-test result and the resulting probability value. 
  
f Source waters were collected at different times of the year for these two sets of experiments 
involving either chlorination or chloramination.  g The SCGE genotoxic potency value is the 
concentration factor that was calculated, using regression analysis, at the midpoint of the curve 
within the concentration range that expressed above 70% cell viability. h The coefficient of 
determination for the regression analysis upon which the genotoxic potency value was 
calculated.  i Lowest genotoxic concentration factor of the water concentrate in the concentration-
response curve that induced significant genomic DNA damage as compared to the negative 
control.  j Non-genotoxic.  k Not significant. 
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Iopamidol 
62883-00-5 
776.85 Da 
 
Iomeprol 
78649-41-
9 
776.85 Da 
Iopromide 
73334-07-3 
790.87 Da 
 
Iohexol 
66108-95-
0 
820.88 Da 
Diatrizoate 
737-31-5 
613.77 Da 
 
 
 
Figure 2.1 Chemical structures of ICM commonly used for medical imaging. 
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Figure 2.2  Iodo-DBP formation at 72 h of reaction mixtures containing iopamidol, aqueous 
chlorine or chloramine, and natural source waters.  [Cl2]T or [NH2Cl]  = 100 µM, [iopamidol] = 5 
µM, [Buffer] = 10 mM, temperature = 25 °C, and [TOC] = 2.1 mg/L.  Cl2I = 
dichloroiodomethane, ClBrI = bromochloroiodomethane, Br2I = dibromoiodomethane, ClI2 = 
chlorodiiodomethane, BrI2 = bromodiiodomethane, I3 = iodoform, IAA = iodoacetic acid, BrIAA 
= bromoiodoacetic acid, Z = (Z)-3-bromo-3-iodopropenoic acid, E = (E)-3-bromo-3-
iodopropenoic acid, diacid = (E)-2-iodo-3-methylbutenedioic acid. 
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Figure 2.3  Dichloroiodomethane formation as a function of time at pH 8.5 in reaction mixtures 
containing iopamidol, natural source waters, and (A) aqueous chlorine, or (B) monochloramine.  
[Cl2]T = 100 µM, [Buffer] = 10 mM, temperature = 25 °C, and total organic carbon [TOC] = 2.1 
mg/L.   
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Figure 2.4 Proposed pathway for formation of iodo-DBPs from iopamidol.  
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Figure 2.5  Iodo-THM formation at 24 h of reaction mixtures containing iodide, NOM, and 
aqueous chlorine (A) or monochloramine (B).  [Cl2]T = 100 µM, [I-] = 5 µM, [Buffer] = 10 mM, 
temperature = 25 °C, and total organic carbon [TOC] = 2.1 mg/L.  Cl2I = dichloroiodomethane, 
ClBrI = bromochloroiodomethane, Br2I = dibromoiodomethane, ClI2 = chlorodiiodomethane, 
BrI2 = bromodiiodomethane, I3 = iodoform, IAA = iodoacetic acid, BrIAA = bromoiodoacetic 
acid, I2AA = diiodoacetic acid, Z = (Z)-3-bromo-3-iodopropenoic acid, E = (E)-3-bromo-3-
iodopropenoic acid, diacid = (E)-2-iodo-3-methylbutenedioic acid. 
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Figure 2.6  (A) Concentration-response curves of CHO cell chronic cytotoxicity of organic extracts of 
Athens-Clarke County (ACC) source water with iopamidol (IPM), ACC water after chlorination, and 
ACC water plus iopamidol plus chlorination (for reactions carried out at pH 7.5).  (B) Concentration-
response curves of CHO cell chronic cytotoxicity of organic extracts of ACC source water with IPM, 
ACC water after chloramination, and ACC water plus IPM plus chloramination.  (C) Concentration-
response curves of CHO cell acute genotoxicity of organic extracts of ACC water with IPM, ACC water 
after chlorination, and ACC water plus IPM plus chlorination.  (D) Concentration-response curves of 
CHO cell acute genotoxicity of organic extracts of ACC water with IPM, ACC water after 
chloramination, and ACC water plus IPM plus chloramination.  Note:  ACC source waters for the 
chlorination and chloramination experiments, respectively, were collected at two different times in the 
year. 
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CHAPTER 3 
Nitrosamines, Nitramines, and Complex Mixtures  
Associated with Amine-based Carbon Capture Systems 
 
3.1 Introduction 
 Toxicology has applications to nearly any biological or engineering question. Exposure to 
physical and chemical agents in the environment can damage the biological integrity of tissues or 
organisms, causing adverse consequences for biological systems and organisms. A growing 
concern about global climate change and greenhouse gas emissions has encouraged engineers 
and energy utilities to investigate possible measures to limit greenhouse gas emissions to the 
atmosphere. While the enthusiasm for this innovation is needed, a successful response to the 
challenge of climate change must not ultimately cause sufficient harm to the environment so as 
to simply exchange one problem for another. By integrating biological toxicology into 
engineering decisions surrounding the development of amine-based carbon capture technologies, 
scientists and engineers can work together to develop and improve best practices associated with 
carbon capture systems. Currently, Statoil ASA in Norway is developing the largest commercial-
scale carbon sequestration facility attached to a fossil fuel power plant at Mongstad. With 
supporting analytical biological work, the toxicology data can help to direct this facility and 
subsequent carbon capture plants towards the safest optimal procedures. 
 
3.2 Carbon Capture Process and Chemistry 
 The amine-based carbon capture systems being used in pilot facilities today and proposed 
for the Statoil facility in Mongstad are not a new idea. Amine solvents have been used for 
decades to remove acid gasses, including CO2 and H2S, from natural gas. Efforts to use amines 
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specifically for the capture of carbon were piloted during the late 1970s and early 1980s in an 
attempt to provide an economical source for carbon dioxide to be used for enhanced oil recovery, 
but the process did not prove to be profitable and the technology was not introduced to 
commercial-scale power plants [1]. Additional applications include using amines to capture 
dilute carbon dioxide from air supplies on submarines [2]. With the advent of carbon taxes and 
an increased attention to global climate change, interest in carbon capture has been renewed for 
economic and environmental reasons. This type of emissions control is especially appealing 
because the amine-capture technology has already been proven effective at capturing 70-90% of 
CO2 and can be adopted by existing coal-fired power plants by retrofitting with absorber and 
regenerator columns in a manner similar to the addition of sulfur controls [1]. 
 The CO2 is removed from flue gas by the addition of a number of steps following the 
combustion controls already in place. The emissions from the combustion (energy generating) 
stage are scrubbed for removal of acidic gases that are already subject to regulations. Rather than 
being released, the gas is modified, to alter the temperature or other gaseous constituents, for 
example, in order to enhance the efficiency of capture. The modified stream is sent through a 
secondary scrubber to strip CO2 from the effluent. The aqueous amine solution is sprayed over 
the gas and collects at the base of the column. This material is then recovered and undergoes 
physical alterations to release the CO2 for collection and regenerate the solvent for reuse (Figure 
3.1). Side reactions during both CO2 collection and release can result in unexpected by-products 
and loss of solvent. Understanding these processes are essential for informed assessment of both 
the efficiency of the process as well as any potential hazards it presents to human health and the 
environment. 
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 While a variety of amines can be used in the carbon capture process, the fundamental 
chemistry remains unchanged. When the amine solution is introduced to the flue gas stream in 
the absorber column (Figure 3.2), the acidic carbon dioxide gas reacts with the basic amine 
solution and forms a water-soluble product. When heated in the regenerator column, the reaction 
reverses, releasing the carbon dioxide and regenerating the amine to be recycled through the 
absorber column again [3, 4]. A number of different but related mechanisms have been proposed 
but can be simplistically summarized in Figure 3.3. After the carbon dioxide is captured, changes 
in heat and pressure liberate the CO2 and give off a stream of water and carbon dioxide. The gas 
must first be dried before the CO2 can be condensed and stored. 
 While much of the solvent is regenerated, there is some loss every cycle. The amines 
used are very sensitive to other materials typically found in flue gas from coal-fired power 
plants. SOX is a main concern, as SO2 levels of less than 10 ppm are advisable but typical 
concentrations for flue gases from coal-fired power plants range from 700-2500 ppsm [1]. NOX are 
also constituents of concern, with NO2 being the most important species for side reactions. 
Oxygen, fly ash, and carbon monoxide are also believed to be responsible for fouling of the 
solvent and producing heat-stable amine salts that can promote further corrosion, but these 
reactions have not been thoroughly investigated [1]. Generalizations about the performance of 
amine carbon capture systems on coal-fired power plants is further complicated by the variation 
in type and quality of coal used by a given facility, resulting in varying compositions of flue gas 
from source to source [5, 6]. 
 The reactive amines can also cause corrosion problems, placing an upper limit on the 
total concentration of the amine in solution of 20-30% amine by weight. The process’s efficiency 
is also strained because flue gasses from many power plants are relatively lean in carbon dioxide, 
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comprising less than 15% of the stream and leaving an abundance of materials that can 
potentially react in undesirable ways with the amine. The low concentrations require high rates 
of solvent cycling. Coal flue gas is typically released at ambient pressure and relatively high 
temperatures, encouraging degradation of the amine. 
 Solvent degradation is more complex and less well understood than the reactions that are 
believed to govern the capture chemistry. A number of pathways have been put forward, but a 
common feature is the production of ammonia and vinyl or an organic acid that serve as 
important intermediates to the mixture of organics recovered in wash water [Figure 3.4] [4]. 
Other mechanisms emphasize a series of radical reactions catalyzed by iron (III) [1, 7]. Harsher 
conditions for absorption and recovery have typically resulted in greater volumes and higher 
toxicity of waste. It is believed that the ammonia generated results from the absorption of O2 
present in the flue gas. An alternative scheme focuses on oxygen [Figure 3.5] [8]. 
 Only two studies attempted to identify actual materials present in the waste water 
following solvent regeneration. A number of organics were identified in the water at the bottom 
of the reclaimer at the IMC Chemicals Facility in Trona, CA [4]. While this work provides a 
basic guideline for chemical constituents in a carbon capture system, cursory investigations for 
the Mongstad facility indicate important differences, such as the detection of nitrosamines. A 
summary table of the more prominent constituents found by Strazisar and colleagues is presented 
in Table 3.1 [4]. 
 This diverse array of products certainly qualifies as a complex mixture. Because of the 
variety of materials produced in side reactions with the solvents involved in the carbon 
sequestration systems, toxicology testing must be done on complex mixtures. In assessing these 
complex mixtures, constituents expected to be major contributors to the overall toxicity of the 
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samples are being investigated as well. Assays can be developed to capture enough information 
about a given mixture to compare its relative toxicity and potential to harm the environment to 
other alternatives. In this way, the analytical biology can direct a technology towards a more 
benign process. 
 
3.3 Priority Individual Agents 
Nitrosamines have been identified as a primary concern as byproducts of the carbon 
sequestration process. As a chemical class, nitrosamines have been shown to be highly 
carcinogenic. Of the over 300 nitrosamines tested for carcinogenicity, approximately 90% were 
positive [9]. Tests of individual nitrosamines have shown a number of interesting features, 
including an observable carcinogenic effect on all species tested and a high degree of organ 
specificity in carcinogenic activity. The nitrosamines are promutagens and require cytochrome 
P450-mediated metabolic activation to induce DNA damage. Most respond to a rat liver 
microsomal fraction such as S9. 
 Nitramines are expected to be important by-products of carbon capture systems. 
Structurally, the nitramines are very similar to the nitrosamines. The nitramines have an 
additional oxygen atom bonded to the secondary nitrogen instead of the nitrosamine’s single 
oxygen, providing resonance stabilization that helps to explain the lower reactivity of the 
chemical class. Nitramine stability has historically meant less attention in the literature, as the 
nitrosamines more frequently deliver positive toxicity results. While less reactive, their stability 
gives the nitramines a longer persistence in the environment. Without a thorough investigation of 
their toxicity, the assumptions on relative safety of nitramine constituents in the effluent have not 
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been confirmed. This study represents the first systematic, analytical, comparative toxicity 
studies of the two chemical classes together. 
 Beyond the scope of the immediate project, nitrosamines and nitramines are 
independently important environmental contaminants. Both are nearly ubiquitous and have many 
routes of exposure to humans. These nitrogenous materials are found in as diverse media as 
cooked or processed foods, personal care products, tobacco smoke, and drinking water. 
Detection in drinking waters is on the rise as more utilities convert from chlorine disinfectant to 
chloramine to come into compliance with the Stage 2 rules. Further impacted source waters for 
drinking water utilities, caused by increased development and rising populations, also provide 
additional available nitrogen that can be converted into these contaminants [10]. Nitrosamines 
can even be generated endogenously when nitrites encounter the acidic environment in the 
stomach [11]. The research described in this thesis has broad relevance both within and beyond 
the project at hand. Individual agents identified for analysis and their structures are presented in 
Table 3.2 and Figure 3.6, respectively. 
 
3.4 Materials and Methods 
3.4.1 Reagents 
General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO). Media and fetal bovine serum (FBS) were purchased from 
Hyclone Laboratories (Logan, UT) or from Fisher Scientific Co. (Itasca, IL). 
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3.4.2 Safety 
 All experiments were conducted in certified stage 2 biological safety cabinets. Waste was 
stored of in designated “Toxic Waste” bins and disposed of in accordance with the University of 
Illinois’s safety policies. 
 
3.4.3 Mammalian Cell Culture 
 Chinese hamster ovary (CHO) cells have been widely employed in in vitro toxicology 
studies. An image of CHO cells is presented in Figure 3.7. As a mammalian cell line, they more 
closely parallel human and animal tissues than the bacterial models such as E. coli and S. 
typhimurium. CHO are also very stable models – they express normal morphology and cell 
contact inhibition, contain a stable chromosome complement, and have a consistent cell doubling 
time. These features are often not true of transformed or tumor cell lines, making data from the 
neoplastic cell lines less consistent than with CHO studies. Transgenic CHO cell line AS52 was 
derived from the parental CHO K1-BH4 line [12]. Isolated clone 11-4-8 is used here [13, 14]. 
  Cells were maintained by growing on glass culture plates with Hams F12 medium and 
5% fetal bovine serum (FBS) and incubated at 37°C in a humidified atmosphere of 5% CO2. 
When plates became confluent, cells were trypsinized and transferred to a new plate with fresh 
medium to continue the line. 
 
3.4.4 CHO Chronic Cytotoxicity 
 The CHO chronic cytotoxicity assay measures cell density as a factor of the 
concentration of a test agent after a 72 h (three cell cycles) exposure. The assay was conducted in 
a 96-well, flat-bottomed microplate. Each of the columns represented a different treatment 
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group. Column 1 was loaded with the negative control, 3×103 CHO cells in 200 µL F12+FBS 
without any test agent. Column 2 was used for a blank with no cells but 200 µL of F12+FBS and 
used to measure the intrinsic absorbency of the plate. Ten concentrations of agent and 3×103 
cells were loaded in a volume of 200 µL of F12+FBS in columns 3-12. 8 rows (A-H) provided 
technical repeats and helped to establish statistical power. An illustration of the plate set-up is 
included as Figure 3.8. After all treatments were added to the plate, wells were covered with 
sterile AlumaSeal™ and incubated for 72 h at 37ºC. 
 After the 72 h exposure period, the cells progressed through three cell cycles and, if no 
toxicity was observed, reached a density of approximately 2.4×104. The supernatant was 
aspirated off the wells and transferred to a designated waste container for disposal. The cells 
were fixed to the plate with the addition of 50 µL of methanol per well. After 10 min, the 
methanol was shaken out to dryness and 50 µL of a 1% crystal violet (1:1 methanol:water v/v) 
was gently added to each well. Wells were stained for 10 min, washed with tap water, and tapped 
dry, leaving the stained cells adhering to the plate. Into each well, 50 µL of a 75% DMSO 25% 
methanol solution was added and the plate was incubated at room temperature for a final 10 min. 
The plate was analyzed for light absorbance at 595 nm on a BioRad microplate reader. 
Absorbance data for each well was recorded and transferred to an Excel spreadsheet. The data 
for each well were corrected by subtracting off the average “blank” well absorbance value, and 
normalized as a percentage of the negative control. 
 A one-way analysis of variance (ANOVA) test was used to determine if the agent or 
complex mixture induced a statistically significant level of killing. If a significant F value (P ≤ 
0.05) was obtained, a Holm-Sidak multiple comparison versus the control group analysis was 
conducted. The power of the test statistic was maintained as 0.8 at α = 0.05. A concentration-
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response curve was generated and regression analysis was used to calculate a %C½ (LC50) value 
or the concentration where the cell density is equal to 50% of the negative control. The LC50 was 
used to compare the rank order of toxicity between different compounds or mixtures. 
 
3.4.5 CHO Genotoxicity 
 Acute genotoxicty was measured with single-cell gel electrophoresis (SCGE). SCGE 
quantitatively measures genomic DNA damage in cell nuclei [15]. The day before an 
experiment, 4×104 cells and 200 µL F12+FBS were added to 11 wells of a clean, UV-sterilized 
96-well microplate and incubated overnight at 37°C in a humidified, 5% CO2 incubator. On the 
day of treatment, the medium was aspirated from the wells and the cells were washed twice with 
Hank’s Balanced Salt Solution (HBSS). Dilutions of chemical agent were made from stock 
solutions in DMSO (stored at -20°C). For experiments requiring metabolic activation, an S9b150 
mix was prepared [16]. Experiments consisted of 11 treatment groups, including a negative 
control, nine concentrations of test agent or mixture, and a positive control. For non-S9 
experiments, the positive control was 3.8 mM of ethylmethanesulfonate and all treatments were 
conducted in a final volume of 25 µL F12. With S9, 750 mM NDMA was used as a positive 
control and the final volume of treatment groups was 100 µL, 20 µL of which was the S9 
mixture. After the addition of the treatments, the wells were covered with sterile AlumaSeal™ 
and incubated for 4 h at 37°C. 
Following the incubation, the AlumaSeal™ was removed and the medium aspirated from 
the wells. Cells were again washed twice with HBSS and then harvested using trypsin. To check 
for acute cytotoxicity, a 10 µL sample of the cells was collected and stained with Trypan Blue 
vital dye and cells were manually counted to determine a percent acute toxicity. For analysis, cell 
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viability was kept at 70% or greater. The remaining mixture was embedded in an agarose 
microgel and the cell membranes were lysed. After lysing, the microgels were incubated at 4ºC 
in alkaline electrophoresis buffer for 20 min, allowing the DNA to denature. The microgels were 
electrophoresed for 40 min. The microgels were neutralized with neutralization buffer and either 
dried in methanol for future analysis or immediately stained with ethidium bromide and analyzed 
using Comet IV software. Genomic DNA damage was measured as % tail DNA, or the amount 
of DNA that has migrated from the nucleus into the agarose during electrophoresis [15]. A 
summary of this procedure is presented in Figure 3.9. The average % tail for each microgel was 
used as the unit of measure. Data were analyzed in SigmaPlot, a concentration-response curve 
was generated and a regression analysis was used to fit a curve to the data. Genotoxic potency 
was measured as the midpoint of the % tail DNA curve. An ANOVA test was used to determine 
statistical significance of treatment groups. If a significant F value (P ≤ 0.05) was obtained, a 
Holm-Sidak multiple comparison versus the control group analysis was conducted. The power of 
the test statistic was maintained as 0.8 at α = 0.05. 
 
3.4.6 CHO Cytotoxicity 
 The general measure of cytotoxicity was determined with a chronic assay. CHO cells 
were uniformly loaded in a 96-well microplate with a concurrent negative control and blank, and 
treatment wells were exposed to a range of concentrations of a test agent for a 72 h incubation 
period. After incubation, the supernatant was evacuated, the remaining cells were fixed to the 
wells and dyed with crystal violent stain and the absorbance of each well is measured. This assay 
has proven to be a consistent, accurate, and rapid way of assessing the relative toxicity of direct-
acting agents of interest [15]. 
50 
 
 The nitrosamines and nitramines, however, require metabolic activation to be 
metabolized into toxic agents. This consideration is important, as exposure to a potential toxicant 
will result in processing by the metabolic systems in the liver and potentially leading to the 
formation of problematic secondary products. The 72 h chronic cytotoxicity assay, however, is 
unable to accurately measure the toxicity of agents that require metabolic activation for a variety 
of reasons. For in vitro assays, an additional S9 mixture, a system of salts, cofactors, and 
microsomes isolated from rats, must be added to the supernatant of cells and test agent to mimic 
the metabolic activities of an in vivo exposure. Due to the high salt content of the activation 
system, exposure to the S9 resulted in enhanced toxicity to cells if extended past a few hours, 
eliminating the possibility of a chronic test.  
The materials in the S9 mix also precipitated out of the supernatant over a short time 
period, coating the cells at the bottom of the wells. This extra layer of material caused an 
increase in the absorbance of individual wells in a manner not related to the relative 
concentration of the dye being measured. The cells themselves are significantly less likely to 
detach in the presence of S9 and the S9 probably was not efficiently washed from wells. Dead 
cells remaining in the wells after washing will absorb crystal violet dye into their membranes and 
will be measured as if they were live cells, confounding the results. 
Instead of using crystal violet, efforts were made to modify an XTT (2,3-bis-(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide, disodium salt) to measure cytotoxicity. 
This approach was applied to a short-term exposure to a test agent for a time period used in the 
SCGE measures of genotoxicity employed in the rest of this study. XTT is a dye that, when 
reduced in the mitochondria, undergoes a color change from yellow to orange. The absorbance of 
this material provides a measure of mitochondrial activity and gives an indication of the survival 
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of the exposed cells. Cells exposed to the toxicant will show less viability at concentrations that 
cause killing, ending their ability to convert the XTT dyes to the orange color and providing a 
signal in the supernatant of mitochondrial activity. The supernatant can then be moved to fresh 
wells, unimpeded by the precipitates from the S9, and absorbance can be measured. 
As a proof of concept, a variable number of cells were loaded onto a 96-well microplate 
and incubated overnight, allowing them to attach to the wells. The following day, the cells were 
washed twice with HBSS and exposed to F12 and S9 and allowed to incubate for 4 h. After 
treatment, the cells were washed twice more and XTT/menadione mixture in filter-sterilized 
HBSS was added. The cells were incubated for an additional 3 hours before absorbance was 
measured on a spectrophotometer at 450 nm. The total volume of supernatant from each well 
was then transferred to a clean well and the absorbance was measured again. From these data, a 
blank absorbancy associated with the XTT/menadione-only wells was subtracted from the total 
absorbance of wells of that volume. The data for these volumes was then transformed to a 
measure of the percentage of the highest (confluent) loading of cells. Curves for each 
concentration selected indicated that the XTT assay can still be utilized in the presence of S9 and 
provides relatively consistent data at all but the highest volumes of XTT. The experiment was 
repeated, with the additional step of taking the XTT materials aspirated from the treatment wells 
and moving them into centrifuge tubes, where they were then spun down for 3 minutes at 3000 
rpm before being carefully aspirated again into clean wells. This additional step to remove any 
carry-over precipitates enhanced accuracy of measurement, albeit slightly. 
 While the modified XTT assay could provide accurate and repeatable data when known 
cell counts were added to wells, it ultimately provided little additional information for this 
project. After using the maximum possible concentrations of test agent as limited by the DMSO 
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percentage in the final well volume, no cytotoxicity was observed. It was inferred that the 
nitrosamines and nitramines, while active mutagens and genotoxins, were not sufficiently acutely 
toxic to show a depressed survival in these cells over the 4 h treatment times at these 
concentrations. The XTT toxicity assay modifications in this research project provided a 
promising approach to other scenarios in assays that also have measurement interference with 
absorption. 
 
3.4.7 Salmonella typhimurium Mutagenicity Assay 
 S. typhimurium tester strain YG7108 (hisG46, rfa; (chl, uvrB, bio) adaST; ogtST; Cmr; 
Ampr) was used in this assay due to its sensitivity to nitrosamines and other alkylating agents. 
The strain was provided by Dr. T. Nohmi, National Institute of Health Sciences, Tokyo, Japan 
[17]. Test agents or mixtures that induce base pair substitution mutations will cause a mutation at 
hisG46 (Figure 3.10) to return the bacteria to the wild type phenotype, allowing it to grow on a 
selective VB medium (Figure 3.11). 
 A master plate was used to maintain the bacterial culture. The bacteria were streaked 
across an LB plate and grown overnight in a humidified 37ºC incubator, then sealed with 
parafilm and stored at 4ºC until needed. The day before treatment, a single-colony isolate was 
grown in a 100 mL LB medium with 25 µg/mL kanamycin and 10 µg/mL chloramphenicol at 
37°C and shaken at 200 rpm [17]. On the day of treatment, the culture was centrifuged at 5000 
rpm for 5 min. The supernatant was discarded and the bacterial pellet was gently suspended in 50 
mL 100 mM potassium-phosphate buffer (PPB). The material was centrifuged again, the 
supernatant discarded, and the pellet suspended in 2.5-3 mL of PPB. A 50 µL aliquot of the 
bacteria suspension was added to 4.95 mL PPB and vortexed. The solution’s optical density was 
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measured at 660 nm. The optical density corresponds to the concentration of bacteria in the tube. 
The bacteria from the suspension were used to make a titer of 6×109 bacteria/mL in a volume 
determined by the size of the experiment. The titered bacteria were stored on ice until the time of 
treatment. 
 Dilutions of the complex mixtures or individual agents were prepared in PPB. For assays 
utilizing mammalian metabolic activation systems, an S9 complex was mixed and included 50 
mM PPB pH 7.4, 10 mM MgCl2, 5 mM glucose-6-phosphate, 30 mM KCl, and 4 mM NADP 
plus 200 µL/mL of Aroclor 1254-induced rat hepatic microsomal suspension (S9), with the final 
S9 concentration in the treatment well at 7%. Bacteria and test agent, with or without S9 mixture, 
were added to a UV-sterilized, round-bottomed 96-well microplate. The treatment wells were 
sealed with AlumaSeal™ and incubated at 37ºC and shaken at 200 rpm for 60 min. 
 
3.5 Results 
 Eleven pure compounds, nitrosamines and nitramines, were assayed for chronic 
cytotoxicity and for genotoxicity both with and without S9 activation. Twelve complex mixtures 
of washwaters were also assayed over the course of this project. 
 
3.5.1 CHO Chronic Cytotoxicity 
 Data from each compound or mixture were averaged and are plotted as a percentage of 
the negative control versus the concentration or concentration factor. The chronic cytotoxicity of 
the complex mixtures showed distinct differences between samples, but most of the nitrosamines 
and nitramines did not exhibit chronic cytotoxicity without metabolic activation. Exceptions to 
this pattern included a lower cell density at 12.5 mM in Nitrosomorpholine, 10 mM 
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Nitrosopiperazine, 10 mM Nitropiperazine, 1,4-Dinitrosopiperazine, and the most pronounced 
decline in 1,4-Dinitropiperazine. Evidently, these agents express a toxic effect without S9 
activation contrary to predictions about the chemical classes as a whole. Individual 
concentration-response curves for N-Nitrosodiethanolamine (Figure 3.12), N-
Nitrodiethanolamine (Figure 3.13), N-Nitromethylethanolamine (Figure 3.14), N-
Nitrosodimethylamine (Figure 3.15), N-Nitrodimethylamine (Figure 3.16), N-Nitrosomorpholine 
(Figure 3.17), N-Nitromorpholine (Figure 3.18), 1-Nitrosopiperazine (Figure 3.19), 1-
Nitropiperazine (Figure 3.20), 1,4-Dinitrosopiperazine (Figure 3.21), and 1,4-Dinitropiperazine 
(Figure 3.22). 
 All complex mixtures were toxic over the concentration range used. Their concentration-
response curves are split between two graphs (Figure 3.23 and Figure 3.24) with an additional 
sample presented in Figure 3.25. A summary bar graph using the %C½ (Figure 3.26) illustrates a 
direct comparison between the different treatments. The disparities in toxicity between different 
trials show that the risks posed by the carbon capture by-products vary across experimental 
conditions. If the causal conditions can be identified, then the industrial process can be adapted 
to shift its by-product output to a more benign composition. The most cytotoxic samples were 
found to be A10-0075 > A10-0075 (preserved with sulfamic acid) >> A10-0029 > A10-0017. 
The remaining samples had more similar toxicities. It is important to note that when the chemical 
characteristics of the materials were compared, the priority nitrogenous materials did not provide 
the majority of the toxic response. In this way, the biological data was able to identify an 
important factor in safety that was not immediately obvious by only considering the 
concentrations of the priority contaminants. 
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3.5.2 Induction of Genomic DNA Damage by Priority Agents 
 The mean % tail was determined over a range of concentrations that did not result in 
significant acute cytotoxicity (over 70% viability was required). Due to the small sample sizes of 
the complex mixture material, only two were assayed for genotoxicity.  
 For the pure compounds, the nitroso- and nitro- analogs can be compared in terms of 
genotoxicity. Three samples were found to be genotoxic in CHO cells with S9 metabolic 
activation, and followed a pattern of NDMA > Nitrosomorpholine > 1,4-Dinitrosopiperazine. 
Their analogous nitramines did not induce genomic DNA damage. Nitrosodiethanolamine, 
Nitrodiethanolamine, Nitrosopiperazine, and Nitropiperazine were not genotoxic in CHO cells 
with or without metabolic activation. Individual concentration response curves with applicable 
cell viability are presented for Nitrosdiethanolamine (Figure 3.27), Nitrodiethanolamine (Figure 
3.28), nitromonoethanolamine (Figure 3.29), NDMA (Figure 3.30), Nitrodimethylamine (Figure 
3.31), Nitrosomorpholine (Figure 3.32), Nitromorpholine (Figure 3.33), 1,4-Dinitrosopiperazine 
(Figure 3.34), 1,4-Dinitropiperazine (Figure 3.35), Nitrosopiperazine (Figure 3.36), and 
Nitropiperazine (Figure 3.37). The two complex mixtures assayed for genotoxicity, A10-0054 
(Figure 3.38) and A10-0171 (Figure 3.39) were negative over 500 or 1000 times concentration 
without S9B150 metabolic activation – again, limitations on sample size prevented the use of the 
larger volume S9 assay. 
 
3.5.3 Mutagenicity Results in S. typhimurium 
 Although CHO cells are useful and informative as in vitro models, bacterial mutagenicity 
assays offer a different set of advantages. While a rapid assay in CHO can provide insight into 
whether or not an agent or mixture damages the genome, the S. typhimurium allows for an 
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analysis of mutation. Genotoxicity is necessary but not sufficient for the mutagenicity and the S. 
typhimurium model allows for the investigation of actual mutants from a sample. Strain YG7108 
was also selected to be more sensitive that the CHO cells to these agents. Especially when using 
S9 metabolic activation, the simpler cells of S. typhimurium might be more able to glean 
differences between individual agents and complex mixtures. 
 With the S. typhimurium assay, nine of the priority compounds were found to be mutagenic 
while two were negative over the concentration ranges tested. Nitrosodiemthylamine, the model 
nitrosamine in most of the literature, was by far the most mutagenic and required metabolic 
activation for its mutagenic activity (Figure 3.40). Its analogous nitramine, nitrodimethylamine, 
was found to be less mutagenic but still active with metabolic activation but inactive without it 
(Figure 3.41). Nitrosomorpholine was positive only with S9 (Figure 3.42), as was its analogous 
nitramine, Nitromorpholine (Figure 3.43). For 1,4-Dinitrosopiperazine, again, the sample is 
positive in the presence of S9 but not without it (Figure 3.44). The 1,4-Dinitropiperazine is 
mutagenic both with and without S9, deviating from the activity patterns of the other nitroso- and 
nitramines and indicating a different mechanism of action for mutagenicity (Figure 3.45). 
Nitrosodiethanolamine was found to be mutagenic both with and without S9 at very high 
concentrations and exhibiting a higher level of mutagenicity with S9, perhaps indicating multiple 
pathways of mutagenicity (Figure 3.46). Nitrodiethanolamine, unlike its analogous nitrosamine, 
was only active in the absence of S9 (Figure 3.47). Nitromonoethanolamine, much like the 1,4-
Dinitropiperazine, was equally mutagenic both with and without S9 activation (Figure 3.48). 
Both N-Nitrosopiperazine (Figure 3.49) and N-Nitropiperazine (Figure 3.50) were not active 
mutagens with or without S9. A summary slide, including the “mutagenic potency” method of 
comparison, is included as Table 3.3. 
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 Cursory analysis of complex mixtures for mutagenicity provided valuable insight into 
process characteristics of carbon capture and biological endpoints. As previously stated, CHO 
toxicity was unable to determine a relationship between different individual agents and the 
overall toxicity of complex mixtures. Early S. typhimurium mutagenicity data, however, did 
present an important finding. From the first set of complex mixtures provided by the company 
(Figure 3.51 and Figure 3.52), the mutagenicity of the samples was very divergent. Though not 
all of the inputs were available, from the chemical information that was available suggested a 
relationship between NOX in the entering gas and the mutagenicity of the effluent was positive 
and is illustrated in (Figure 3.53). Samples A10-0054 and A10-0171 were further assayed, as 
they were in CHO. In S. typhimurium, A10-0054 was not mutagenic over the concentration range 
tested, but produced significant toxicity at higher concentrations in the absence of S9 (Figure 
3.54). In A10-0171, the mixture was found to be mutagenic both with and without S9 metabolic 
activation, but with reduced mutagenicity in the presence of S9 (Figure 3.55). These profiles are 
unusual and indicate that the driving forces of the mixtures as a whole are not from agents that 
require metabolic activation, indicating that perhaps the focus of hazard mitigation in carbon 
capture should focus on direct acting mutagens rather than the nitrogenous promutagens of this 
study. 
 
3.6 Discussion 
 This research progress considers both single-compound and complex mixture toxicity, 
examining both the traditional paradigm of risk assessment as measurements of single 
compounds as well as the toxicity associated with whole mixtures. The results of both types of 
experiments are enlightening. 
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 First, the model organism and assay type are important considerations when assessing novel 
mixtures. Sensitivity is especially important to distinguish between unknown samples. Because 
of their sensitivity, YG7108 was able to provide much more specific response information than 
the CHO cells. Had the assay only been conducted in mammalian cells, the results would have 
been less sensitive as CHO cells were only able to detect a few differences. 
 Second, the complex mixtures told a very different story than the original project had 
expected. While NDMA and other nitrogenous materials are important topics of study because 
they are ubiquitous in the environment and are positive in a number of our assays, the complex 
mixture samples here showed that the overall toxicity, both cytotoxicity and mutagenicity, is not 
driven by these priority agents. The total quantifiable nitrogenous materials present in the 
samples could not account for the cytotoxicity and mutagenicity observed. The changes in cell 
viability in the S. typhimurium assays show that rather than enhance their toxicity and 
mutagenicity, the metabolic activation actually tempers these biological outcomes. The most 
important constituents were not the nitrosamines and nitramines – they were the unknowns that 
are direct-acting agents. In the same way, the comparative toxicology of complex mixtures was 
able to illustrate, with the S. typhimurium data, that a given input (NOX) was very important to 
the ultimate toxicity of a sample, moreso than relative concentrations of the priority compounds. 
 Third, this study begins to elucidate a number of important features of the relationship 
between nitrosamines and their analogous nitramines, which have broad applications beyond the 
scope of this project. Most obviously, the relationships between Nitroso/nitrodimethylamine, 
Nitroso/nitromorpholine, 1,4-Nitroso/nitropiperazine, and 1-Nitroso/nitropiperazine show a 
relationship between the activity of the nitrosamine and nitramines through both CHO and S. 
typhimurium. In S. typhimurium +S9, NDMA > Nitrosomorpholine > 1,4-Nitrosopiperazine. In 
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the same way, Nitrodimethylamine > Nitromorpholine > 1,4-Nitropiperazine. In CHO, which 
were less sensitive than the S. typhimurium, showed the same pattern of genotoxicity, NDMA > 
Nitrosomorpholine > 1,4-Nitrosopiperazine, but no activity with the weaker nitramines. The 1-
Nitrosopiperazine and 1-Nitropiperazine were negative across all assays, also suggesting a 
relationship based on structure. 
 Additionally, a number of results were surprising and diverged from expectations of activity. 
Nitrosodiethanolamine was mutagenic at very high concentrations both with and without S9, but became 
more mutagenic with metabolic activation. NDELA can be inferred to have multiple pathways of 
mutagenicity, one as a direct actor and a more efficient pathway that relies on metabolic activation. 
Nitromonoethanolamine and 1,4-Dinitropiperazine were active both with and without S9 with the same 
activity, indicating an activity that does not require metabolic activation and not characterized by the S9-
dependant alkylation model of NDMA. Nitrodiethanolamine, perhaps most perplexingly, was only active 
without S9 and was found to be negative with the activation. Further investigation of the events resulting 
in mutagenicity would provide insight into the potential activity pathways of these important classes of 
compounds. 
 
3.7 Conclusions 
• The emerging focus on chemical mixtures in toxicology is uniquely equipped to handle a 
number of complicated environmental questions, including the optimization of emerging 
engineering technologies. 
• Mixtures can allow for the assessment of constituents that are not specifically being 
sought out – the priority nitrosamines and nitramines only constitute a small fraction of 
the whole mixture. 
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• Nitrosamines and nitramines do, in some cases, share some relationship due to their 
structure, as the NDMA/NO2DMA, Nitrosomorpholine/Nitromorpholine, and 1,4-
Dinitrosopiperazine/1,4-Dinitropiperazine illustrated. 
• Not all nitramines follow the same mechanism of action, as 1,4-Dinitropiperazine was 
found to be mutagenic both with and without S9 metabolic activation, bucking the trend 
seen in most of the nitrosamines and other nitramines. 
• Despite the emphasis on nitrosamine and nitramine toxicity in the project proposal for 
StatOil, the toxicological data from the samples indicate that other chemical constituents, 
not simply the nitrogenous materials, are responsible for the bulk of the toxic effects 
observed. 
• In this case, biological information provided important feedback to technological 
development to direct technical solutions towards less environmentally-hazardous 
alternatives. Because the assays used in this research were able to identify product sets 
that were more toxic and the mutagenicity assay specifically pointed to the % NOX in air 
in the absorber column as related to enhanced mutagenicity, more information was 
available to the company about toxicology even beyond the few priority agents. 
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Table 3.1 Identified compounds from monoethanolamine reclaimer column from a CO2 capture 
facility [4]. 
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Table 3.2 Priority Nitrosamines and Nitramines. 
Name Formula CAS # 
N-Nitrosodiethanolamine C4H10N2O3 1116-54-7 
N-Nitrodiethanolamine C4H10N2O4 4185-47-1 
N-Nitromonoethanolamine C2H6N2O3 unavailable 
N-Nitrosomorpholine C4H8N2O2 59-89-2 
N-Nitromorpholine C4H8N2O3 4164-32-3 
N-Nitrosodimethylamine C2H6N2O 62-75-9 
N-Nitrodimethylamine C2H6N2O2 4164-28-7 
1-Nitrosopiperazine C4H9N3O 5632-47-3 
1-Nitropiperazine C4H9N3O2 42499-41-2 
1,4-Dinitrosopiperazine C4H8N4O2 140-79-4 
1,4-Dinitropiperazine C4H8N4O3 4164-37-8 
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Table 3.3 Summary of S. typhimurium assay results. 
 
Compound CAS # 
Salmonella typhimurium YG7108 Reversion Assay 
Conc. 
Range 
(µM) 
S9 
2× 
Mutat. 
Conc. 
(µM) 
r2 
Mutagenic 
Potency 
(rev/µmol) 
N-Nitrosodimethylamine 62-75-9 50 – 5000 −S9 Neg NA Neg 
N-Nitrosodimethylamine 62-75-9 1.25 –  10000 +S9 4.5 0.98 21642 
N-Nitrodimethylamine 4164-28-7 50 – 7500 −S9 Neg NA Neg 
N-Nitrodimethylamine 4164-28-7 50 – 7500 +S9 279.6 0.99 1660 
N-Nitrosomorpholine 59-89-2 100 – 7500 −S9 Neg NA Neg 
N-Nitrosomorpholine 59-89-2 5 – 7500 +S9 21.4 0.99 6724 
N-Nitromorpholine 4164-32-3 100 – 7500 −S9 Neg NA Neg 
N-Nitromorpholine 4164-32-3 100 – 7500 +S9 1177.2 0.99 272 
N-Nitroso-
diethanolamine 1116-54-7 7500 – 30000 −S9 
26838 0.95 10 
N-Nitroso-
diethanolamine 1116-54-7 7500 – 30000 +S9 10304 0.95 22 
N-Nitrodiethanolamine 4185-47-1 10000 – 30000 
−S9 25193 0.95 8 
N-Nitrodiethanolamine 4185-47-1 7500 – 30000 +S9 Neg NA Neg 
1-Nitrosopiperazine 5632-47-3 100 – 7500 −S9 Neg NA Neg 
1-Nitrosopiperazine 5632-47-3 100 – 7500 +S9 Neg NA Neg 
1-Nitropiperazine 42499-41-2 500 – 10000 −S9 Neg NA Neg 
1-Nitropiperazine 42499-41-2 500 – 7500 +S9 Neg NA Neg 
1,4-Dinitrosopiperazine 140-79-4 100 – 7500 −S9 Neg NA Neg 
1,4-Dinitrosopiperazine 140-79-4 100 – 7500 +S9 49.1 0.99 1263 
1,4-Dinitropiperazine 4164-37-8 5000 – 20000 −S9 2118 0.99 157 
1,4-Dinitropiperazine 4164-37-8 1000 – 20000 +S9 1099 0.99 191 
N-Nitromono-
ethanolamine Unavailable 
5000 –  
30000 
−S9 1732 0.99 134 
N-Nitromono-
ethanolamine Unavailable 
5000 – 
30000 
+S9 1366 0.99 133 
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Figure 3.1 Schematic of CO2 Capture System [18]. 
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Figure 3.2 Detail of the Absorber Column [18]. 
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Figure 3.3 General chemistry of amine-based carbon capture [19]. 
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Figure 3.4 A proposed solvent degradation pathway [4]. 
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Figure 3.5 A proposed oxygen-centric degradation pathway [7-8]  
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Figure 3.6 Structures of A) N-nitrosodimethylamine B) N-nitrodimethylamine C) N-
nitrosodiethylamine D) N-nitrosodipropylamine E) N-nitrosodibutylamine F) N-
nitrosomethylethylamine G) N-nitrosopyrrolidine H) N-nitrosopiperidine I) N-nitrosomorpholine 
J) N-nitromorpholine [18]. 
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Figure 3.7 Image of Chinese Hamster Ovary (CHO) Cells, AS52, Clone 11-4-8. 
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Figure 3.8 Summary of Plate Set-up for CHO Cytotoxicity. 
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Figure 3.9  Summary of SCGE Procedure. 
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Figure 3.10 S. typhimurium reverse mutation assay. 
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Figure 3.11 Reverse mutations of S. typhimurium increases as the concentration of the mutagen 
increases.   
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Figure 3.12 Nitrosodiethanolamine shows no toxicity in the chronic cytotoxicity assay. 
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Figure 3.13 A concentration-response curve for Nitrodiethanolamine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.14 A concentration-response curve for Nitromethylethanolamine after a 72-hour 
chronic cytotoxicity exposure. 
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Figure 3.15 Concentration-response curve for NDMA after a 72-hour chronic cytotoxicity 
exposure. 
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Figure 3.16 Concentration-response curve for Nitrodimethylamine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.17 Concentration-response curve for Nitrosomorpholine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.18 Concentration-response curve for Nitromorpholine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.19 Concentration-response curve for Nitrosopiperazine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.20 Concentration-response curve for N-Nitropiperazine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.21 Concentration-response curve for 1,4-Dinitrosopiperazine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.22 Concentration-response curve for 1,4-Dinitropiperazine after a 72-hour chronic 
cytotoxicity exposure. 
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Figure 3.23 Cytotoxicity concentration-response curves for washwater samples A10-0014, A10-
0017, A10-0029, A10-0033, A10-0039 after a 72 h exposure. 
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Figure 3.24 Cytotoxicity concentration-response curves for washwater samples A10-0047, A10-
0052, A10-0054, A10-0058, and A10-0058 Control. 
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Figure 3.25 Concentration-response curve for A10-0075 with and without Sulfamic Acid 
Preservative. 
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Figure 3.26 Summary of Cytotoxic Potency of Complex Mixtures. 
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Figure 3.27 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to Nitrosodiethanolamine. 
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Figure 3.28 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to Nitrodiethanolamine. 
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Figure 3.29 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to Nitromonoethanolamine. 
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Figure 3.30 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to NDMA. 
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Figure 3.31 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to N-Nitrodimethylamine. 
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Figure 3.32 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to N-Nitrosomorpholine. 
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Figure 3.33 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to N-Nitromorpholine. 
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Figure 3.34 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to 1,4-Dinitrosopiperazine. 
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Figure 3.35 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to 1,4-Dinitropiperazine. 
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Figure 3.36 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to 1-Nitrosopiperazine. 
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Figure 3.37 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to 1-Nitropiperazine. 
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Figure 3.38 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to A11-0054. 
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Figure 3.39 Concentration-response curves for acute genomic DNA damage after 4 h exposure 
to A11-0171. 
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Figure 3.40 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to N-Nitrosodimethylamine. 
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Figure 3.41 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitrodimethylamine. 
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Figure 3.42 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitrosomorpholine. 
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Figure 3.43 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitromorpholine. 
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Figure 3.44 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to 1,4-Dinitrosopiperazine. 
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Figure 3.45 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to 1,4-Dinitropiperazine. 
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Figure 3.46 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitrosodiethanolamine. 
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Figure 3.47 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitrodiethanolamine. 
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Figure 3.48 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to Nitromonoethanolamine. 
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Figure 3.49 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to 1-Nitrosopiperazine. 
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Figure 3.50 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to 1-Nitropiperazine. 
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Figure 3.51 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to complex mixtures A10-0014, A10-0017, A10-0029, A10-0033, A10-0039 (no 
cytotoxicity). 
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Figure 3.52 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to complex mixtures A10-0047, A10-0052, A10-0054, A10-0058, A10-0058 Control 
(no cytotoxicity). 
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Figure 3.53 Mutagenicity in S. typhimurium as a factor of %NOx in Air in Absorber. 
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Figure 3.54 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to complex mixture A10-0054.  
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Figure 3.55 Concentration-response curves for mutagenicity in S. typhimurium after 1 h 
exposure to complex mixture A10-0171.  
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CHAPTER 4 
Conclusions 
 
• Organisms experience chemical exposures as complex mixtures. 
• Interactions between individual constituents, or the effects of individual constituents 
below the limits of detection, make the traditional single-compound approach to 
toxicology and regulation necessarily incomplete. 
• The emerging focus on chemical mixtures in toxicology is uniquely equipped to handle a 
number of complicated environmental questions. 
• Complex mixtures can help us to confirm hypotheses, such as the origins of highly toxic 
individual constituents in drinking water emerging from organic substrates rather than the 
expected inorganic iodide. 
• Mixtures can also help us to assess constituents that are not being sought out – the change 
in toxicity due to the addition of iopamidol is greater than simply accounting for 
previously identified iodinated DBPs. 
• Nitrosamines and nitramines do, in some cases, share some relationship due to their 
structure, as the NDMA/NO2DMA, Nitrosomorpholine/Nitromorpholine, and 1,4-
Dinitrosopiperazine/1,4-Dinitropiperazine illustrated. 
• Not all nitrosamines follow the same mechanism of action, as 1,4-Dinitropiperazine was 
found to be mutagenic with and without S9 metabolic activation. 
• Despite the emphasis on nitrosamine and nitramine toxicity in the project proposal for 
StatOil, the toxicological data from the samples indicate that other chemical constituents, 
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not simply the nitrogenous materials, are responsible for the bulk of the toxic effects 
observed. 
• Biological information can provide important feedback to technological development to 
direct technical solutions towards less environmentally-hazardous alternatives. 
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APPENDIX A 
Supporting Information for Chapter 2 
 
A.1 ICM Methods   
Water samples were filtered through glass fiber filters (Schleicher and Schuell, Dassel, 
Germany), acidified to pH 3 adding sulfuric acid (3.5 M H2SO4).  One L was extracted via 
BakerbondTM SDB-1 (3 mL, 200 mg, J.T. Baker).  Prior to extraction, all samples were spiked 
with 10 µL of a surrogate solution, consisting of iohexol-d5, iomeprol-d3, iopamidol-d3, 
diatrizoate-d6, desmethoxyiopromide (DMI), and desdihydroxypropyliopromide (DDHPI) (20 
ng/µL).  DMI and DDHPI were kindly provided by Bayer Schering Pharma (Berlin, Germany), 
diatrizoate-d6 was purchased from Campro Scientific (Berlin, Germany), and iohexol-d5, 
iomeprol-d3, and iopamidol-d3 were purchased from Toronto Research Chemicals (North York, 
Canada).  Analytes were eluted with 4×2 mL of methanol, evaporated to 100 µL using nitrogen 
gas, and reconstituted with 900 µL Milli-Q water.  ICM were detected with liquid 
chromatography (LC)/electrospray ionization (ESI)/MS/MS in the positive ion mode.  An 
Agilent 1200 Series LC system was coupled to a 4000 Q TrapTM MS system (Applied 
Biosystems/MDS Sciex, Darmstadt, Germany).  
Chromatographic separation was achieved on two coupled Chromolith® Performance RP-
18e columns (4.6 mm × 100 mm, Merck, Darmstadt, Germany) equipped with a Chromolith® 
RP-18e guard column (4.6 mm × 5 mm, Merck, Darmstadt, Germany).  Sample aliquots of 50 
µL were injected onto the LC/MS/MS system, and the analytes were eluted from the column 
using two mobile phases, 95% Milli-Q water, 5% methanol, and 0.5% formic acid (A), and 
99.5% methanol and 0.5% formic acid (B).  Further details can be found in Kormos et al. [1].  
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A.2 Iodo-THM and Iodo-Acid Methods 
Water samples were extracted using a previously described method with minor 
modification [2].  The sample was first acidified to pH < 0.5 with 5 mL concentrated H2SO4.  
Then 30 g dried Na2SO4 was added to the sample and shaken by hand until it completely 
dissolved.  The sample was then spiked with 10 uL of 1,2-dibromopropane (25 µg/mL in 
methanol) internal standard  prior to 3 mL of methyl tert-butyl ether (MTBE) being added.  The 
samples were then placed on a wrist-action shaker for 30 min.  The sample was allowed to settle 
and the MTBE extract was removed and dried with a plug of dried Na2SO4.  The sample was 
then split, with 0.5 mL removed for methylation/derivatization with diazomethane for analysis of 
iodo-acids, and the remaining sample was used to analyze for iodo-trihalomethanes (iodo-
THMs). 
Six iodo-THMs (dichloroiodomethane, bromochloroiodomethane, dibromoiodomethane, 
chlorodiiodomethane, bromodiiodomethane, and iodoform) were measured in the extracts using 
gas chromatography (GC)/electron ionization (EI)-mass spectrometry (MS), carried out in 
selected ion monitoring (SIM) mode (m/z 127, representing iodine, and m/z 123 representing the 
internal standard, 1,2-dibromopropane).  Analyses were carried out on either a Hewlett-Packard 
6890 gas chromatograph equipped with a 5973 mass selective detector (MSD) or a Waters 
Micromass Autospec high resolution mass spectrometer (8 kV, 1000 resolution, and a source 
temperature of 200oC) .  GC conditions were as follows: 30-m Restek Rtx-5 or J&W 
Scientific/Agilent DB-5 column with a 0.25-mm ID and 0.5 or 0.25-µm film thickness.  The 
injection port was controlled at 250oC, and GC/MS transfer lines at 280oC.  Injections of 1.0 µL 
of the extracts were introduced via a split/splitless injector (in splitless mode).  The GC 
temperature program consisted of an initial temperature of 35oC, which was held for 10 min, 
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followed by an increase at a rate of 3oC/min to 45oC, and increased again at a rate of 25 oC /min 
to 280oC, which was held for 18 min.   
 Five iodo-acids (iodoacetic acid, bromoiodoacetic acid, (Z)-3-bromo-3-iodo-propenoic 
acid, (E)-3-bromo-3-iodo-propenoic acid, and (E)-2-iodo-3-methylbutenedioic acid) were 
measured in the extracts according to a previously published procedure using derivatization and 
analysis with GC/negative chemical ionization (NCI)-MS [2].  Diiodoacetic acid was also 
included in the experiments involving iodide.  The derivatization procedure was modified 
slightly from the earlier published method [3] because the commercial reagent for generating 
diazomethane recently changed from 1-methyl-3-nitro-2-nitrosoguanidine (MNNG) to Diazald 
(Sigma-Aldrich).  Briefly, this involved the generation of diazomethane by dissolving 0.367g 
Diazald (Sigma Aldrich, St. Louis, MO) in 1 mL carbitol in the inner part of a diazomethane 
generator (Sigma Aldrich), adding 2-3 mL of MTBE in the outer part of the reactor, closing the 
vessel and immersing in ice.  The reaction was then initiated by adding 1.5 mL KOH (37%) to 
the inner vessel, and allowed to proceed for 1 h.  The diazomethane formed collected in the 
MTBE, and 0.250 mL of this solution was added to the treated water extract (0.5 mL) and 
allowed to react for approx. 30 min, after which it was quenched with approximately 50 mg 
activated silica (for 30 min).   
 GC/NCI-MS analyses were carried out in SIM mode (on the m/z 127 ion, representing 
iodine) on a Shimadzu QP2010 Plus GC/mass spectrometer.  The Shimadzu mass spectrometer 
was operated at a source temperature of 200oC and electron energy of 124 eV.  Methane was 
used as the CI gas.  Injections of 0.5 µL of the extract were introduced via a split/splitless 
injector (in splitless mode) onto a GC column (DB-5, 30-m x 0.25 mm id, 0.25 µm film 
thickness, J&W Scientific/Agilent).  The GC temperature program consisted of an initial 
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temperature of 40oC, which was held for 1 min, followed by an increase at a rate of 12oC/min to 
150oC, which was held for 5 min, followed by an increase at a rate of 25oC/min to 280oC, which 
was held for 14.8 min.  The injection port temperature was controlled at 250oC, and GC/MS 
transfer lines at 280oC. Calibration standards of the synthesized iodo-acid methyl esters 
(synthesis reported in reference [2]) were measured with each set of samples analyzed 
quantitatively.   
 
A.3 Fulvic and Humic Acid Experiments 
 Suwannee River fulvic and humic acids (International Humic Substances Society) were 
reacted individually in purified water at pH 7.5 using 5 µM iopamidol and 100 µM chlorine or 
monochloramine at increasing concentrations of fulvic or humic acid (1 to 20 mg/L).  Reaction 
conditions were the same as carried out for experiments using real source waters.  Samples were 
extracted at 24, 48, and 72 h and analyzed for iodo-THMs and iodo-acids using the methods 
described above.   
 
A.4 Chinese Hamster Ovary (CHO) Cell Assays 
A.4.1 Reagents   
General reagents were purchased from Fisher Scientific Co. (Itasca, IL) and Sigma 
Chemical Co. (St. Louis, MO).  Media and fetal bovine serum (FBS) were purchased from 
Hyclone Laboratories (Logan, UT).  The water organic extracts were received from U.S. EPA in 
ethyl acetate.  The ethyl acetate was concentrated such that the organics from 1 L of water 
sample were dissolved in 10 µL ethyl acetate (105× concentration).  The organic samples were 
solvent transferred to dimethyl sulfoxide (DMSO) and stored at −22°C in sterile glass vials. 
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Chinese hamster ovary (CHO) cells, line AS52, clone 11-4-8 were used in all biological assays. 
The CHO cells were maintained in Ham’s F12 medium containing 5% FBS at 37°C in a 
humidified atmosphere of 5% CO2. 
 
A.4.2 CHO Cell Chronic Cytotoxicity Assay  
 This assay measures the reduction in cell density as a function of the organic extract 
concentration over a period of approximately 3 cell divisions (72 h).  Chronic cytotoxicity to 
CHO cells was measured using an assay we previously developed for the analysis of DBPs [4].  
Flat-bottom, tissue culture 96-well microplates were employed; 4-8 replicate wells were prepared 
for each concentration of a specific organic extract. Eight wells were reserved for the blank 
control consisting of 200 µL of F12 medium + 5% fetal bovine serum (FBS).  The negative 
control consisted of 8 wells containing 100 µL of a titered CHO cell suspension (3×104 cells/mL) 
plus 100 µL F12 + FBS.  The wells for the remaining columns contained 3,000 CHO cells, F12 + 
FBS and a known concentration of an organic extract for a total of 200 µL.  To prevent cross-
over contamination between wells due to volatilization of the organic extract, a sheet of sterile 
AlumnaSeal™ (RPI Corporation, Mt. Prospect, IL) was pressed over the wells before the 
microplate was covered.  The microplate was placed on a rocking platform for 10 min to 
uniformly distribute the cells, and then placed in a tissue culture incubator for 72 h.  After 
incubation, each well was gently aspirated, fixed in 100% methanol for 10 min, and stained for 
10 min with a 1% crystal violet solution in 50% methanol.  The plate was gently washed, and 50 
µL of dimethyl sulfoxide/methanol (3:1 v/v) was added to each well for 10 min.  The plate was 
analyzed in a BioRad microplate reader at 595 nm.  The data were automatically recorded and 
transferred to an Excel spreadsheet on a microcomputer connected to the microplate reader.  The 
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blank-corrected absorbancy value of the negative control (cells with medium only) was set at 
100%.  The absorbancy for each treatment group well was converted into a percentage of the 
negative control.  For each organic extract concentration, 4-8 replicate wells were analyzed per 
experiment, and the experiments were repeated. 
 
A.4.3 Single Cell Gel Electrophoresis Assay 
 Single cell gel electrophoresis (SCGE) is a molecular genetic assay that quantitatively 
measures the level of genomic DNA damage induced in individual nuclei of treated cells [5].  
The day before treatment, 4×104 CHO cells were added to each microplate well in 200 µL of F12 
+ 5% FBS and incubated.  The next day, the cells were washed with Hank’s balanced salt 
solution (HBSS) and treated with a series of concentrations of a specific organic extract in F12 
medium without FBS in a total volume of 25 µL for 4 h at 37°C, 5% CO2.  The wells were 
covered with sterile AlumnaSeal™.  After incubation, the cells were washed 2× with HBSS and 
harvested with 50 µL of 0.01% trypsin + 53 µM EDTA.  The trypsin was inactivated with 70 µL 
of F12 + FBS.  Acute cytotoxicity was measured from a 10 µL aliquot of cell suspension mixed 
with 10 µL of 0.05% trypan blue vital dye in phosphate-buffered saline (PBS).  SCGE data were 
not used if the acute cytotoxicity exceeded 30%.  The remaining cell suspension from each well 
was embedded in a layer of low melting point agarose prepared with PBS upon clear microscope 
slides that were previously coated with a layer of 1% normal melting point agarose prepared with 
deionized water and dried overnight.  The cellular membranes were removed by an overnight 
immersion in lysing solution at 4°C.  The microgels were placed in an alkaline buffer (pH 13.5) 
in an electrophoresis tank, and the DNA was denatured for 20 min.  The microgels were 
electrophoresed at 25 V, 300 mA (0.72 V/cm) for 40 min at 4°C.  The microgels were 
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neutralized with Tris buffer (pH 7.5), rinsed in cold water, dehydrated in cold methanol, dried at 
50°C, and stored at room temperature in a covered slide box.  For analysis, the microgels were 
hydrated in cold water for 30 min and stained with 65 µL of ethidium bromide (20 µg/mL) for 3 
min.  The microgels were rinsed in cold water and analyzed with a Zeiss fluorescence 
microscope with an excitation filter of BP 546/10 nm and a barrier filter of 590 nm.  For each 
experiment, 2 microgels were prepared per treatment group. Randomly chosen nuclei (25 per 
microgel) were analyzed using a charged coupled device camera.  A computerized image 
analysis system (Komet version 3.1, Kinetic Imaging Ltd., Liverpool, UK) was employed to 
determine the SCGE % tail DNA value of the nuclei as indices of DNA damage.  The digitalized 
data were automatically transferred to a computer based spreadsheet for subsequent statistical 
analysis.  Within each experiment, a negative control, a positive control (3.8 mM ethylmethane-
sulfonate), and 9 concentrations of an organic extract were analyzed concurrently.  The 
experiments were repeated 2-3 times for each organic extract.  
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Table A.1  Unusual Plants from Iodo-DBP Occurrence Studya. 
Drinking Water 
Plant 
Iodide (µg/L) Sum iodo-acids 
(µg/L) 
Sum iodo-THMs 
(µg/L) 
Plant 2 1.0 0.37 4.9 
Plant 4 ND 0.10 1.2 
Plant 11 1.5 0.21 2.3 
Plant 15 ND 0.17 2.4 
aND = Non-detect; detection limit = 0.13 µg/L 
 
 
  
131 
 
Table A.2 NOM and Source Water Characteristics for Athens-Clarke County (ACC) Raw 
Source Watera. 
 TOC SUVA254 [Br-] [I-] [NH3]T 
Source (mg/L-C) (L/m-mg) (µM) (µM) (µM) 
ACC 2.1 4.88 0.15 ND ND 
a[NH3]T = [NH4+] + [NH3]; ND = Non-detect; detection limits = 0.5 µM and 1.0 µM for NH3 and 
I-, respectively. 
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Table A.3 Iodo-DBP Formation from Iopamidol in the Absence of NOM a. 
HOCl NH2Cl 
Iodo-DBPs 
(nM) 
pH pH 
6.5 7.5 8.5 9.0 6.5 7.5 9.0 
Cl2 I 2.2 3.6 5.8 10.7 5.3 5.0 3.1 
Cl Br I <0.5 0.5 <0.5 0.9 1.0 0.6 <0.5 
Br2 I <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 0.5 
Cl I2 <0.5 <0.5 <0.5 <0.5 2.8 4.6 3.3 
Br I2 <0.5 <0.5 <0.5 <0.5 <0.5 0.8 <0.5 
I3 <0.5 <0.5 <0.5 <0.5 0.6 <0.5 <0.5 
IAA <0.5 <0.5 <0.5 <0.5 1.4 3.5 1.5 
BrIAA <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Z <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
E <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Diacid <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
a
 Iodo-DBP formation at 72 h of reaction mixtures containing iopamidol and aqueous chlorine or 
monochloramine in purified water.  [Cl2]T  or [NH2Cl] = 100 µM, [Iopamidol] = 5 µM, [Buffer] 
= 10 mM, temperature = 25 °C.  Cl2I = dichloroiodomethane, ClBrI = bromochloroiodomethane, 
Br2I = dibromoiodomethane, ClI2 = chlorodiiodomethane, BrI2 = bromodiiodomethane, I3 = 
iodoform, IAA = iodoacetic acid, BrIAA = bromoiodoacetic acid, Z = (Z)-3-bromo-3-
iodopropenoic acid, E = (E)-3-bromo-3-iodopropenoic acid, diacid = (E)-2-iodo-3-
methylbutenedioic acid. 
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Table A.4  Iodo-DBP Formation from Iopamidol in the Presence of NOM (Athens-Clarke 
County [ACC] Raw Source Water) a. 
Iodo-DBPs 
(nM) 
HOCl NH2Cl 
pH pH 
6.5 7.5 8.5 6.5 7.5 9.0 
Cl2 I 43.7 171.9 211.8 11.0 6.3 0.6 
Cl Br I 0.6 1.4 1.3 0.8 <0.5 <0.5 
Br2 I <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Cl I2 12.2 75.6 41.5 8.6 4.9 <0.5 
Br I2 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
I3 <0.5 1.2 <0.5 <0.5 <0.5 <0.5 
IAA 2.0 3.0 1.9 4.0 1.4 0.6 
BrIAA <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Z <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
E <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Diacid <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
a
 Iodo-DBP formation at 72 h of reaction mixtures containing iopamidol, aqueous chlorine or 
monochloramine, and natural source waters.  [Cl2]T  or [NH2Cl] = 100 µM, [Iopamidol] = 5 µM, 
[Buffer] = 10 mM, temperature = 25 °C, and total organic carbon [TOC] = 2.1 mg/L.  Cl2I = 
dichloroiodomethane, ClBrI = bromochloroiodomethane, Br2I = dibromoiodomethane, ClI2 = 
chlorodiiodomethane, BrI2 = bromodiiodomethane, I3 = iodoform, IAA = iodoacetic acid, 
BrIAA = bromoiodoacetic acid, Z = (Z)-3-bromo-3-iodopropenoic acid, E = (E)-3-bromo-3-
iodopropenoic acid, diacid = (E)-2-iodo-3-methylbutenedioic acid. 
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Table A.5  Iodo-DBP Formation for Other ICM—Reaction with Chlorine in the Presence of 
NOM (in Athens-Clarke County [ACC] Raw Source Water) a. 
Iodo-DBPs 
(nM) 
Iohexol Iopromide 
pH pH 
6.5 7.5 8.5 6.5 7.5 8.5 
Cl2 I 4.3 5.2 10.0 4.7 4.9 9.6 
Cl Br I <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Br2 I <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Cl I2 0.7 <0.5 2.4 1.2 <0.5 2.1 
Br I2 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
I3 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
IAA <0.5 <0.5 0.5 <0.5 <0.5 9.6 
BrIAA <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Z <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
E <0.5 <0.5 <0.5 <0.5 <0.5 2.1 
Diacid <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
a
 Iodo-DBP formation at 72 h of reaction mixtures containing iohexol or iopromide, aqueous 
chlorine, and natural source waters.  [Cl2]T   = 100 µM, [ICM] = 5 µM, [Buffer] = 10 mM, 
temperature = 25 °C, and total organic carbon [TOC] = 2.1 mg/L.  Cl2I = dichloroiodomethane, 
ClBrI = bromochloroiodomethane, Br2I = dibromoiodomethane, ClI2 = chlorodiiodomethane, 
BrI2 = bromodiiodomethane, IAA = iodoacetic acid, BrIAA = bromoiodoacetic acid, Z = (Z)-3-
bromo-3-iodopropenoic acid, E = (Z)-3-bromo-3-iodopropenoic acid, diacid = (E)-2-iodo-3-
methylbutenedioic acid. 
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Table A.6  Iodo-DBP Formation for Other ICM— Reaction with Monochloramine in the 
Presence of NOM (in Athens-Clarke County [ACC] Raw Source Water) a. 
Iohexol Iopromide 
Iodo-DBPs 
(nM) 
pH pH 
6.5 7.5 8.5 6.5 7.5 8.5 
Cl2 I 6.4 4.7 0.5 4.7 3.9 0.9 
Cl Br I 0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Br2 I <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Cl I2 3.2 3.0 <0.5 1.3 1.8 <0.5 
Br I2 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
I3 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
IAA 3.6 2.0 0.5 2.4 1.9 0.6 
BrIAA <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Z <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
E <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
Diacid <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 
 
a
 Iodo-DBP formation at 72 h of reaction mixtures containing iohexol or iopromide, aqueous 
monochloramine, and natural source waters.  [NH2Cl]   = 100 µM, [ICM] = 5 µM, [Buffer] = 10 
mM, temperature = 25 °C, and total organic carbon [TOC] = 2.1 mg/L.  Cl2I = 
dichloroiodomethane, ClBrI = bromochloroiodomethane, Br2I = dibromoiodomethane, ClI2 = 
chlorodiiodomethane, BrI2 = bromodiiodomethane, IAA = iodoacetic acid, BrIAA = 
bromoiodoacetic acid, Z = (Z)-3-bromo-3-iodopropenoic acid, E = (Z)-3-bromo-3-iodopropenoic 
acid, diacid = (E)-2-iodo-3-methylbutenedioic acid. 
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Figure A.1  Iodate formation as a function of time and pH in reaction mixtures containing 
iopamidol and aqueous chlorine.  [Cl2]T = 100 µM, [iopamidol] = 5 µM,   [Buffer] = 10 mM, and 
temperature = 25 °C.   
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Figure A.2  Iodo-THM and iodo-acid formation at 72 h as a function of increasing humic acid 
(A) or fulvic acid (B) concentration in reaction mixtures containing iopamidol and aqueous 
chlorine.  [Cl2]T = 100 µM, [iopamidol] = 5 µM,   pH = 7.5, [Buffer] = 10 mM, and temperature 
= 25 °C.   
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Figure A.3  Pseudo first-order rate contant as a function of time and pH in reaction mixtures 
containing iopamidol and aqueous chlorine.  [Cl2]T = 100 µM, [iopamidol] = 5 µM,   [Buffer] = 
10 mM, and temperature = 25 °C.   
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Figure A.4 Proposed mechanism for formation of iodo-DBPs with chlorine and chloramine 
disinfection (adapted from [6, 7]).  Estimated rate constant of 2 x 10-3M-1 s-1 for the NH2Cl + 
HOI reaction and 2 x 10-3M-1 s-1 if OI- is the reactive species.   
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